etoposide has been researched along with Cancer, Embryonal in 555 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 78 (14.05) | 18.7374 |
1990's | 116 (20.90) | 18.2507 |
2000's | 124 (22.34) | 29.6817 |
2010's | 176 (31.71) | 24.3611 |
2020's | 61 (10.99) | 2.80 |
Authors | Studies |
---|---|
Bansal, D; Jain, R; Kakkar, N; Menon, P; Radhika, S; Rao, KLN; Trehan, A | 1 |
Di, Y; Kang, L; Qiu, G; Ren, C; Wang, Q; Zhao, J | 1 |
Albers, P; Bolenz, C; Brandt, MP; Dieckmann, KP; Dotzauer, R; Haferkamp, A; Heidenreich, A; Hiester, A; Loosen, SH; Nestler, T; Nettersheim, D; Paffenholz, P; Pfister, D; Ruckes, C; Ruf, C; Schmelz, HU; Syring, I; Zengerling, F | 1 |
Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T | 1 |
Moore, KJ; Snow, S; Wood, LA | 1 |
Asher, R; Connolly, EA; Forgeson, G; Goh, J; Grimison, P; Hamad, N; Heller, GZ; Hill, S; Joshi, A; Kuchel, A; Lewin, J; Liow, E; McKenzie, J; Tan, A; Tan, H; Toner, G; Tran, B; Tung, ILY; Walpole, E; Wang, Y; Weickhardt, A; Wickham, A; Winstanley, MA; Wong, V | 1 |
Akamatsu, S; Hama, Y; Kobayashi, T; Koterazawa, S; Masui, K; Sawada, A; Takahashi, Y | 1 |
Hayashi, T; Hiki, M; Masuda, K; Miura, K; Nagata, Y; Seto, K; Shukuya, T; Suzuki, K; Tajima, K; Takahashi, K; Takahashi, R; Tanabe, Y; Watanabe, T | 1 |
Guo, F; Pi, G; Shi, H; Wang, H; Xia, H; Xu, P | 1 |
Blanc, E; Chabaud, S; Dijoud, F; Dumesnil, C; Faure-Conter, C; Flechon, A; Fresneau, B; Hameury, F; Mansuy, L; Orbach, D; Renard, M; Rome, A; Sudour-Bonnange, H; Thebaud, E; Verité, C | 1 |
Abonour, R; Abu Zaid, M; Adra, N; Chovanec, M; Einhorn, L | 1 |
Abe, T; Fukuhara, S; Imamura, R; Kiuchi, H; Nonomura, N; Osaki, H; Uemura, M; Yamanaka, K | 1 |
Badira, CP; Banavali, S; Chinnaswamy, G; Kembhavi, S; Khanna, N; Laskar, S; Muckaden, MA; Prasad, M; Qureshi, S; Ramadwar, M; Ramanathan, S; Vora, T | 1 |
Abonour, R; Adra, N; Akel, R; Althouse, SK; Anouti, B; Einhorn, LH; Hanna, NH; Taza, F; Zaid, MA | 1 |
Bandak, M; Daugaard, G; Johansen, C; Kreiberg, M; Lauritsen, J; Nielsen, KS; Pissinger, C; Rosenvilde, J; Wagner, T | 1 |
Che, Y; Chen, J; Chen, Z; Cheng, X; Chu, R; Huang, C; Jiang, J; Kong, B; Li, J; Li, K; Li, L; Liu, P; Pan, X; Song, K; Song, L; Wang, J; Xue, Y; Yao, S; Zhang, X; Zhao, Y | 1 |
Faria, TMV; Guimarães, RFDC; Jorge, GEM; Lopes, LF; Macedo, CRPD; Navarro, G; Seber, A; Vidal, DO; Villela, NC; Zecchin, VG | 1 |
Al-Ezzi, EM; Crump, M; Hamilton, RJ; Hansen, AR; Hotte, SJ; Jiang, DM; Kollmannsberger, CK; Kuruvilla, J; Nappi, L; North, SA; Soulières, D; Winquist, E; Wood, L; Zahralliyali, A | 1 |
He, L; Li, Y; Wang, F; Zhang, L; Zhao, L; Zheng, X | 1 |
Chandra, S; McKean, H | 1 |
Abe, T; Chiba, H; Iwahara, N; Kikuchi, H; Matsumoto, R; Mitsuhashi, T; Miyata, H; Morita, K; Osawa, T; Shinohara, N; Tanaka, H | 1 |
Chargari, C; Coppin, R; Faure-Conter, C; Fresneau, B; Guérin, F; Martelli, H; Orbach, D; Pasquet, M; Patte, C; Piguet, C; Saumet, L; Sudour-Bonnange, H; Vérité, C | 1 |
Fu, D; Ge, JP; Jia, RP; Li, P; Wu, D; Xu, XF | 1 |
Aguiar, X; Bergamini, A; Fotopoulou, C; Froeling, F; Kaur, B; Papanastasopoulos, P; Ramaswami, R; Rustin, GJS; Sarwar, N; Saso, S; Savage, PM; Seckl, M; Sharma, A; Short, D | 1 |
Armand, C; Benoite, M; Bernichon, E; Bouleftour, W; Chanal, E; Delorme, G; Fournel, P; Guillot, A; Lacroix, B; Langrand-Escure, J; Lardon, R; Levigne, F; Lorin, S; Perraud, Y; Rowinski, E; Tremeau, L; Vallard, A; Vassal, C | 1 |
de Jong, S; Gietema, JA; Looijenga, LHJ; Meijer, C; Rosas Plaza, X; van Agthoven, T; van Vugt, MATM | 1 |
Hashemi, F; Khadivi, F; Razavi, S | 1 |
Agerbæk, M; Andersen, KK; Bandak, M; Daugaard, G; Dehlendorff, C; Gundgaard Kier, MG; Gupta, R; Hansen, MK; Holm, NV; Kreiberg, MB; Lauritsen, J; Skøtt, JW; Wagner, T | 1 |
Biasoni, D; Bisogno, G; Boldrini, R; Conte, M; Crocoli, A; D'Angelo, P; Dall'Igna, P; De Pasquale, MD; Inserra, A; Miele, E; Siracusa, F; Spreafico, F; Terenziani, M | 1 |
Cappellano, AM; Chen, MJ; de Carvalho, ÍT; de Rezende, ACP; Hamerschlak, N; Helito, JK; Sakuraba, RK; Silva, NS; Weltman, E | 1 |
Albany, C; Aparicio, J; Beyer, J; Bokemeyer, C; Cohn-Cedermark, G; Fankhauser, CD; Fischer, S; Gillessen, S; Hamid, AA; Heidenreich, A; Hentrich, M; Klingbiel, D; Koutsoukos, K; Langberg, CW; Lorch, A; Necchi, A; Shamash, J; Ståhl, O; Tandstad, T; Terbuch, A; Thibault, C; Vincenzi, B; Wheater, M; White, J | 1 |
Biró, K; Bodrogi, I; Budai, B; Fazekas, F; Géczi, L; Polk, N | 1 |
Cafferty, FH; Hennig, I; Huddart, RA; Shamash, J; Stenning, SP; White, JD | 1 |
Bijleveld, YA; Bijlsma, JA; Jager, NGL; Sari, V; Westermann, AM | 1 |
Aurilio, G; Bagnardi, V; Cossu Rocca, M; Cullurà, D; Curigliano, G; De Cobelli, O; Frassoni, S; Jereczek-Fossa, BA; Mascia, R; Milani, M; Musi, G; Nolè, F; Omodeo Salè, E; Orsi, F; Verri, E | 1 |
Abonour, R; Adra, N; Albany, C; Althouse, SK; Einhorn, LH; Hanna, NH; Zaid, MA; Zhang, KJ | 1 |
Ahmadi, H; Daneshmand, S; Hamilton, R; Kollmannsberger, C; Nappi, L; Nichols, C | 1 |
Baek, MH; Choi, MC; Chung, YS; Kang, S; Kim, MK; Kim, SI; Kim, YM; Kwon, BS; Lee, JW; Lee, KB; Lee, SH; Lee, SJ; Park, BK; Seong, SJ; Shim, SH; Song, T; Yoo, HJ | 1 |
Meyers, MH; Patel, DA; Trinh, VQ | 1 |
Aoki, S; Hara, K; Muramatsu, H; Nakamura, K; Nishikawa, G; Ono, K; Takayanagi, Y; Tobiume, M; Yamada, Y | 1 |
Adra, N; Einhorn, LH; Hanna, N; Nichols, C | 1 |
Bosl, GJ; Feldman, DR; Funt, SA; McHugh, D | 1 |
Fujiwara, M; Fukui, I; Hayashi, T; Komai, Y; Kouno, T; Numao, N; Takeda, H; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Ishibashi, N; Kondo, T; Mitomo, H; Murakami, K; Nonomura, R; Oshima, Y; Sagawa, M; Sasaki, T; Sugawara, T; Tabata, T | 1 |
Alifrangis, C; Galazi, M; Gjafa, E; Grunewald, T; Ng, K; Shamash, J; Skyllberg, E; Wilson, P | 1 |
Bay, JO; Chatelut, E; Chevreau, C; Delmas, C; Delva, R; Filleron, T; Fléchon, A; Gravis, G; Gross-Goupil, M; Lafont, T; Lotz, JP; Marsili, S; Massart, C; Moeung, S; Thomas, F | 1 |
Acar, R; Arpacı, F; Aykan, MB; Buyukturan, G; Erdem, G; Erturk, I; Esen, R; Karadurmus, N; Kızıloz, H; Urun, Y; Yildiz, B | 1 |
Fukushima, T; Kanda, S; Kato, H; Kobayashi, T; Koizumi, T; Sekiguchi, N | 1 |
Aziri, R; Chovanec, M; Hulova, S; Kolnikova, G; Mardiak, J; Mego, M; Palacka, P; Pindak, D; Rejlekova, K; Vulev, I | 1 |
Albers, P | 1 |
Chiba, D; Hoshi, S; Katsumata, Y; Konno, M; Numahata, K; Otake, K; Satou, M; Takemoto, J | 1 |
Inoue, T; Ishihara, M; Kanda, H; Kato, M; Masui, S; Nishikawa, K; Owa, S; Sasaki, T; Sugimura, Y; Sugino, Y; Watanabe, S; Yoshio, Y | 1 |
Bajorin, DF; Bosl, GJ; Bromberg, M; Carousso, M; Carver, BS; Feldman, DR; Funt, SA; Knezevic, A; McHugh, DJ; Motzer, RJ; O'Donnell, D; Patil, S; Reuter, VE; Sheinfeld, J; Silber, D; Tsai, S | 1 |
Bay, JO; Chatelut, E; Chevreau, C; Ciccolini, J; Culine, S; Delva, R; Filleron, T; Fizazi, K; Flechon, A; Gallois, Y; Gravis, G; Gross-Goupil, M; Guitton, J; Lelièvre, B; Lotz, JP; Massard, C; Moeung, S; Mourey, L; Olivier, P; Paci, A; Thomas, F | 1 |
Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y | 1 |
Bison, B; Friedrich, C; Gerber, NU; Gessi, M; Haberler, C; Juhnke, BO; Kool, M; Kortmann, RD; Kwiecien, R; Mynarek, M; Pfister, SM; Pietsch, T; Rutkowski, S; Schüller, U; Spix, C; Timmermann, B; von Bueren, AO; von Hoff, K; Warmuth-Metz, M | 1 |
Fujii, Y; Fujiwara, M; Fujiwara, R; Fukui, I; Komai, Y; Numao, N; Oguchi, T; Tanaka, H; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Gan, F; He, Y; Li, S; Luo, M; Luo, P; Xie, B; Zhang, S | 1 |
Fabian, P; Kazda, T; Kiss, I; Lakomy, R; Pokrivcak, T; Poprach, A | 1 |
Bandak, M; Daugaard, G; Dehlendorff, C; Jensen, A; Kreiberg, M; Lauritsen, J; Rosenvilde, J; Wagner, T | 1 |
Cameron, AL; Elliss-Brookes, L; Fardus-Reid, F; Feltbower, RG; Fern, L; Fraser, J; Irvine, L; McCabe, MG; Pritchard-Jones, K; Shelton, J; Stiller, C; Wills, L | 1 |
Abonour, R; Abu Zaid, M; Adra, N; Agrawal, V; Albany, C; Althouse, SK; Ashkar, R; Einhorn, LH; Hanna, NH | 1 |
Albers, P; Dieckmann, KP; Fimmers, R; Fingerhut, A; Hartmann, M; Heidenreich, A; Hiester, A; Kliesch, S; Köhrmann, KU; Krege, S; Kwasny, P; Lehmann, J; Loy, V; Niegisch, G; Pechoel, M; Schmelz, HU; Siener, R; Wittekind, C | 1 |
Alrjoub, MM; Alshriedeh, O; Amarin, Z; Sindiani, A | 1 |
Birtle, A; Chowdhury, K; Harland, S; Huddart, R; Joffe, JK; Marshall, MR; Mazhar, D; Sarker, SJ; Shamash, J; Vinnicombe, S; White, J; Wilson, P | 1 |
Bermudez, CA; Deshpande, C; Diamond, J; Golato, JM; Lee, JC; Narayan, V; Vaughn, DJ | 1 |
Anwer, F; Chan, O; Hamdani, AA; Sokolova, A; Ullah, W | 1 |
Barretta, F; Basso, ME; Biasoni, D; Bisogno, G; Boldrini, R; Boschetti, L; Cecchetto, G; Conte, M; D'Angelo, P; De Leonardis, F; De Pasquale, MD; Di Pinto, D; Inserra, A; Siracusa, F; Spreafico, F; Terenziani, M | 1 |
Boulos, S; Mazhar, D; Warren, AY; Wong, HH | 1 |
Alapetite, C; Calaminus, G; Frappaz, D; Garre, ML; Göbel, U; Kortmann, RD; Krefeld, B; Mann, JR; Murray, MJ; Nicholson, JC; Pietsch, T; Ricardi, U; Saran, F; Vasiljevic, A | 1 |
Albany, C; Cary, C; Einhorn, LH; Foster, RS; Hanna, NH; Jacob, JM; Masterson, TA | 1 |
Beyer, J; Fankhauser, CD; Hermanns, T; Roth, L; Sander, S | 1 |
Ben Hassouna, J; Bouzaiene, H; Ghalleb, M; Hadiji, A; Hechiche, M; Rahal, K; Slim, S | 1 |
Richie, JP | 1 |
Culine, S; Gosset, C; Mongiat-Artus, P; Razafimahefa, J; Verine, J | 1 |
Fatima, I; Masood, M; Nisar, H; Sattar, A; Shahid, AB | 1 |
Araki, M; Kobayashi, Y; Maruyama, Y; Mitsui, Y; Nasu, Y; Sadahira, T; Tanimoto, R; Wada, K; Watanabe, M; Watanabe, T | 1 |
Allen, C; Avulova, S; Morgans, A; Moses, KA | 1 |
Khalid, N; Shah, D | 1 |
Bulanov, A; Fainstein, I; Fedyanin, M; Gordeeva, O; Kashia, S; Kurmukov, I; Matveev, V; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Albany, C | 1 |
Pedraza, AM; Stephenson, AJ | 1 |
Adra, N; Albany, C; Calaway, AC; Cary, C; Einhorn, LH; Foster, RS; Hanna, NH; Masterson, TA | 1 |
Chan, H; Davis, ID; Frazier, L; Grimison, P; Lawrence, NJ; Martin, A; Mazhar, D; McDermott, R; Pashankar, F; Stockler, MR; Tan, H; Toner, G; Walker, R; Wong, N; Yeung, A; Yip, S | 1 |
Ismail, H; Khan, RS; Saba, A | 1 |
Fein, DE; Mathew, P; Paulus, JK | 1 |
Hamanaka, K; Hyogotani, A; Koizumi, T; Koyama, T; Matsuoka, S; Sekiguchi, N; Takeda, T; Yamada, K | 1 |
Bedard, PL; Booth, CM; Karim, S; Leveridge, MJ; Robinson, AG; Siemens, DR; Wei, X | 1 |
Aguiar, S; Batista, RMSS; de Cássio Zequi, S; Lopes, A; Mourão, TC | 1 |
Alsdorf, W; Bokemeyer, C; Oing, C; Seidel, C | 1 |
Ahmad, A; Banerjee, S; Berney, DM; Graham, R; Hockings, H; Ledermann, J; Liberale, V; Lockley, M; Murali, K; Newton, C; Sarker, SJ; Shamash, J; Stoneham, S | 1 |
Araki, M; Edamura, K; Kobayashi, Y; Maruyama, Y; Mitsui, Y; Nasu, Y; Sadahira, T; Wada, K; Watanabe, M; Watanabe, T | 1 |
Kollmannsberger, CK; Lavoie, JM | 1 |
Masamba, L; Mtonga, P; Mwafulirwa, K; Nyirenda, R | 1 |
Kuwano, H; Murakawa, T; Murayama, T; Nagayama, K; Nakajima, J; Sano, A; Tsuchiya, T; Yoshida, Y | 1 |
Cai, ZM; Dong, P; Gui, YT; He, YY; Liu, ZW; Lv, ZJ; Wu, S; Yao, K; Zhou, FJ | 1 |
Frazier, AL; Krailo, M; Malogolowkin, MH; Marina, N; Olson, T | 1 |
Gohbara, A; Hanai, T; Kondo, K; Miyoshi, Y; Nakamura, M; Noguchi, K; Sanjyo, H; Takamoto, D; Teranishi, J; Yasuda, K; Yumura, Y | 1 |
Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M | 1 |
Afandiyev, F; Baltacı, S; Bedük, Y; Gülpınar, Ö; Mermerkaya, M; Suer, E; Türkölmez, K | 1 |
Calaminus, G; Friemann, V; Göbel, U; Kyrillopoulou, O; Leuschner, I; Matuschek, C; Mils, O; Rothe, K; Schaper, J; Schneider, DT; Schönberger, S; Wessalowski, R; Willers, R | 1 |
Baek, HJ; Han, JW; Im, HJ; Kang, HJ; Koh, KN; Lee, SH; Park, HJ; Park, KD; Sung, KW | 1 |
Biasoni, D; Catanzaro, M; Farè, E; Giannatempo, P; Gianni, AM; Mariani, L; Milani, A; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Raggi, D; Salvioni, R; Stagni, S; Torelli, T | 1 |
Baranzelli, MC; Corradini, N; Cropet, C; Fasola, S; Faure-Conter, C; Frappaz, D; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Rocourt, N; Rome, A; Thebaud, E; Vérité, C | 1 |
Athanasopoulos, A; Daladimos, T; Kosmas, C; Papachrysanthou, T; Tsavaris, N; Vlachoyiannopoulos, PG | 1 |
Kinoshita, Y; Noguchi, K; Ogawa, T; Saito, K; Suzuki, K; Yumura, Y | 1 |
Bandak, M; Christensen, IJ; Daugaard, G; Lauritsen, J; Thomsen, FB; Thomsen, MF | 1 |
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
Afaq, A; Bomanji, J; Panagiotidis, E; Shankar, A | 1 |
Hayashi, T; Ishii, T; Itami, Y; Kobayashi, Y; Minami, T; Nagai, Y; Nozawa, M; Shimizu, N; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
Bulanov, A; Fedyanin, M; Garin, A; Mosyakova, Y; Pokataev, I; Polockii, B; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Graham, DM; Mayer, NJ; Plant, WD; Power, DG | 1 |
Boland, AL; Chatfield, M; Friedlander, M; Gebski, V; Grimison, PS; Gurney, H; Houghton, B; Kichenadasse, G; Lewis, CR; Rosenthal, M; Singhal, N; Stockler, MR; Thomson, DB; Toner, GC; Vasey, PA; Wong, SS | 1 |
Eungdamrong, J; McLellan, B | 1 |
Billmire, DF; Cullen, JW; Davis, M; Egler, RA; Frazier, AL; Krailo, M; Malogolowkin, MH; Olson, TA; Pashankar, F; Rescorla, FJ; Rodriguez-Galindo, C; Schlatter, MG; Villaluna, D | 1 |
Elsner, P; Grimm, MO; Schummer, C; Tittelbach, J; Winkler, Y | 1 |
Aksoy, S; Alkis, N; Arpaci, E; Babacan, N; Budakoglu, B; Cihan, S; Oksuzoglu, B; Seber, ES; Urun, Y; Yalcin, BC; Yetisyigit, T; Yildirim, N; Zengin, N | 1 |
Daugaard, G; Feldt-Rasmussen, B; Gundgaard, MG; Lauritsen, J; Mortensen, MS; Oturai, PS | 1 |
Bastos, DA; Feldman, DR | 1 |
Abdelaziz, AA; Darweesh, AD; El Gammal, MM; Monir, M; Saber, MM; Salem, SE; Zeeneldin, AA | 1 |
Albany, C; Einhorn, L | 1 |
Adamsen, L; Andersen, JL; Christensen, JF; Daugaard, G; Højman, P; Jones, LW; Jørgensen, LW; Nielsen, RH; Rørth, M; Tolver, A | 1 |
Kato, T; Kiuchi, H; Nagahara, A; Nonomura, N; Oshima, J; Tsujimura, A; Uemura, M | 1 |
Bay, JO; Biron, P; Brindel, I; Bui, BN; Caty, A; de Revel, T; Delva, R; Dubot, C; Fizazi, K; Fléchon, A; Gaulet, M; Geoffrois, L; Gligorov, J; Gravis, G; Horn, E; Lotz, JP; Micléa, JM; Provent, S; Roubaud, G; Selle, F; Soares, DG; Temby, I; Wittnebel, S | 1 |
Arai, Y; Hayashi, Y; Kakimoto, K; Miyago, N; Nakayama, M; Nishimura, K; Takeda, K; Yamaguchi, Y | 1 |
Cafferty, FH; Cullen, MH; Gabe, R; Huddart, RA; Pollock, P; Shamash, J; Stenning, SP; White, JD | 1 |
Cai, RQ; Chen, Y; Li, PF; Lu, SY; Sun, FF; Sun, XF; Wang, J; Wu, SX; Xia, YF; Yang, QY; Zhang, F; Zhen, ZJ; Zhu, J | 1 |
Fujii, Y; Fukui, I; Masuda, H; Sakura, M; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yuasa, T | 1 |
Biasoni, D; Catanzaro, M; Farè, E; Giannatempo, P; Gianni, AM; Marongiu, M; Miceli, R; Necchi, A; Nicolai, N; Piva, L; Raggi, D; Salvioni, R; Stagni, S; Torelli, T | 1 |
Bajorin, DF; Bosl, GJ; Carver, BS; Feldman, DR; Gupta, A; Kundu, SD; Motzer, RJ; Sheinfeld, J | 1 |
Angelsen, A; Cohn-Cedermark, G; Dahl, O; Håkansson, U; Haugnes, HS; Kjellman, A; Oldenburg, J; Solberg, A; Stahl, O; Tandstad, T | 1 |
Cary, KC; Einhorn, LH; Foster, RS; Kaimakliotis, HZ; Masterson, TA; Pedrosa, JA | 1 |
Barone, C; Bengala, C; Biasoni, D; Carlo-Stella, C; Catanzaro, M; Di Nicola, M; Farè, E; Giannatempo, P; Gianni, AM; Lo Vullo, S; Magni, M; Mariani, L; Matteucci, P; Necchi, A; Nicolai, N; Piva, L; Pizzocaro, G; Raggi, D; Salvioni, R; Schiavetto, I; Siena, S; Stagni, S; Torelli, T | 1 |
Agerbaek, M; Christensen, IJ; Daugaard, G; Gupta, R; Kier, MGG; Lauritsen, J; Mortensen, MS | 1 |
Fey, MF; Karamitopoulou-Diamantis, E; Studer, UE; Thalmann, GN; Vidal, AD | 1 |
Cullen, M; Oldenburg, J; Tandstad, T | 1 |
Calaminus, G; Göbel, U; Haas, R; Harms, D; Leuschner, I; Schneider, DT; Schönberger, S; Teske, C | 1 |
Angulo, JC; García-Mediero, JM; García-Tello, A; Gimbernat, H; Ramón de Fata, F; Redondo, C | 1 |
Ando, R; Etani, T; Iida, K; Kawai, N; Kohri, K; Naiki, T; Tozawa, K | 1 |
Abonour, R; Einhorn, LH; Matei, D; Reddy Ammakkanavar, N | 1 |
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C | 1 |
Chen, CA; Chou, CY; Chou, HH; Ho, CM; Huang, YF; Kang, CY; Lin, H; Lu, CH; Wen, KC; Weng, CS; Yu, MH | 1 |
Huang, L; Qian, Z; Qing, J; Wang, Y; Zhao, M; Zhou, F | 1 |
Al-Dandan, S; Alharbi, M; Alharbi, Q; Alharbi, T; Aljamaan, K; Alomari, A; Alsudairy, R; Alsultan, A; Bayoumi, Y; Jarrar, M; Musleh, O | 1 |
Chang, FC; Chang, KP; Chen, HH; Chen, YW; Guo, WY; Ho, DM; Hu, YW; Lai, IC; Lee, YY; Liang, ML; Shiau, CY; Wong, TT; Yen, SH | 1 |
Chang, CY; Chen, KH; Hou, JY; Liang, DC; Liu, HC; Sheu, JC; Yeh, TC | 1 |
de Melo, AC; Lopes da Silva, J; Luiz Renna, N; Paulino, E | 1 |
Batra, S; Karanth, SS; Sharma, D; Vaid, AK | 1 |
Murakawa, Y | 1 |
Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH; Park, JY; Suh, DS | 1 |
Allen, JC; Bouffet, E; Buxton, AB; Chuba, PJ; Donahue, B; Fisher, PG; Goldman, S; Kretschmar, CS; Pollack, IF; Robertson, PL; Zhou, T | 1 |
Fujisawa, M; Miyake, H; Nishikawa, M | 1 |
Bassett, R; Champlin, R; Gulbis, AM; Holmberg, L; Jones, RB; Kingham, A; Ledesma, C; Margolin, K; Nieto, Y; Pagliaro, L; Tannir, N; Tu, SM | 1 |
Brames, MJ; Einhorn, LH; Mulherin, BP | 1 |
Carver, J; Ky, B; Menachem, J; Offin, MD; Squillante, C; Vaughn, D | 1 |
Agerbaek, M; Bandak, M; Daugaard, G; Gupta, R; Holm, NV; Kier, MG; Lauritsen, J; Mortensen, MS | 1 |
Gerwing, M; Hauschild, J; Honecker, F; Höpfner, M; Jacobsen, C; Nitzsche, B; Steinemann, G; von Amsberg, G | 1 |
Albers, P; Fischer, F; Flechtner, HH; Hartmann, M; Siener, R | 1 |
Gilligan, T | 1 |
Aguiar, Sdos S; Almeida, MT; Barreto, JH; Bruniera, P; D'Andrea, ML; de Oliveira, CZ; Lima, ER; Lopes, LF; Lopes, PM; Macedo, CR; Martins, GE; Melaragno, R; Milone, M; Moreira, ME; Pianovski, MA; Sonaglio, V; Vianna, SM; Watanabe, FM | 1 |
Bacon, CL; Bracken-Clarke, D; Browne, PV; Conneally, E; Daly, PA; Flynn, C; Gardiner, N; Hayden, PJ; Kennedy, MJ; Lee, G; McCaffrey, J; Ni Chonghaile, M; O'Donnell, DM; O'Kane, G; Power, D; Vandenberghe, E | 1 |
Biswas, A; Julka, PK | 1 |
Chatfield, M; Friedlander, M; Grimison, P; Gurney, H; Houghton, B; Roncolato, FT; Rosenthal, M; Stockler, M; Thomson, D; Toner, G | 1 |
Arima, N; Kanamaru, H; Oae, M; Okumura, Y; Shiraishi, Y; Soda, T | 1 |
Buizen, L; Friedlander, M; Gebski, V; Grimison, P; Gurney, H; Kichenadasse, G; Lawrence, N; Lewis, C; Martin, A; Rosenthal, M; Singhal, N; Stockler, M; Thomson, D; Toner, G; Vasey, P; Wong, N; Wong, S; Yeung, A | 1 |
Ju, Y; Liang, G; You, C; Zhang, S | 1 |
Adra, N; Albany, C; Einhorn, LH; Giannatempo, P; Hanna, NH; Necchi, A; Nicolai, N; Pond, GR; Raggi, D; Salvioni, R | 1 |
Albany, C; Cary, KC; Chovanec, M; Einhorn, L; Hanna, N | 1 |
Einhorn, LH; Kesler, KA; Ranganath, P | 1 |
Hanai, K; Higure, T; Hoshi, A; Kawamura, Y; Nakajima, N; Nitta, M; Shimizu, Y; Terachi, T | 1 |
Agerbaek, M; Andersen, KK; Bandak, M; Dalton, SO; Daugaard, G; Hansen, MK; Holm, NV; Johansen, C; Kier, MG; Lauritsen, J; Mortensen, MS | 2 |
Beyer, J; Lorch, A | 1 |
Covington, A; Hu, S; McCarthy, D; Mojtahed, A; Thompson, W; Volpicelli, N | 1 |
Dimitriadis, GK; Kosmas, C; Miltiadous, C; Roditis, P | 1 |
Hoshi, T; Ichioka, D; Jouraku, A; Kantori, S; Kawai, K; Kojima, T; Kurobe, M; Miyazaki, J; Nishiyama, H; Sakka, S; Suetomi, T; Tsujimoto, I | 1 |
Kawai, T; Tanaka, Y | 1 |
Pagliaro, LC | 1 |
Aparicio, J; Ayala de la Peña, F; Carmona-Bayonas, A; Castellano, D; Cerezuela, P; Duran, I; Fernandez, A; Fernandez, S; García Del Muro, X; Germà-Lluch, JR; Gonzalez-Billalabeitia, E; Guma, J; Hervas, D; Luengo, MI; Luis Aguilar, J; Manneh, R; Margeli, M; Maroto, P; Mellado, B; Rivera, S; Ros, S; Saenz, A; Sanchez-Muñoz, A; Sastre, J; Sobrevilla, N; Valverde, C | 1 |
Bunne, M; Fosså, SD; Gundersen, POM; Osnes, T; Skalleberg, J; Småstuen, MC; Solheim, O | 1 |
Amatruda, JF; Billmire, DF; Cullen, JW; Dicken, BJ; Egler, RA; Frazier, AL; Krailo, M; Malogolowkin, MH; Olson, TA; Pashankar, F; Rescorla, FJ; Rodriguez-Galindo, C; Ross, JH; Schlatter, M; Shaikh, F; Villaluna, D | 1 |
Grüllich, C; Grüner, M; Hadaschik, B; Hofheinz, RD; Jäger, D; Jentsch-Ullrich, K; Lasitschka, F; Zschäbitz, S | 1 |
Hamasaki, A; Imazu, K; Kai, I; Kazusa, Y; Kodama, M; Kumagai, M; Kusumoto, S; Naito, H; Nakashima, Y; Ueda, K | 1 |
Green, DM | 1 |
Chan, D; Delbès, G; Hales, BF; Pakarinen, P; Robaire, B; Trasler, JM | 1 |
Agarwal, R; Dvorak, CC; Johnston, L; Srinivas, S; Stockerl-Goldstein, KE | 1 |
Aguilar-Ponce, JL; Chilaca-Rosas, F; Cruz-López, JC; Martínez-Cedillo, J; Molina-Calzada, C; Vidal-Millán, S | 1 |
Kawase, T; Mikami, S; Oya, M; Takahashi, S; Yoshida, K | 1 |
Han, H; Li, YH; Liu, ZW; Qin, ZK; Teng, XY; Ye, YL; Yu, SL; Zhou, FJ | 1 |
Arakawa, T; Dalmau, J; Fujisaki, A; Hattori, K; Kimura, M; Onozawa, M; Takeda, K | 1 |
de Assis Almeida, MT; de Camargo, B; Dos Santos Aguiar, S; Lopes, LF; Lopes, PA; Macedo, CR; Mastellaro, MJ; Melaragno, R; Mendonça, N; Pontes, EM; Ribeiro, KB; Santana, VM; Schneider, DT; Sonaglio, V; Vianna, SM | 1 |
Kollmannsberger, C; Nichols, CR | 1 |
Bremnes, RM; Cavallin-Stahl, E; Cohn-Cedermark, G; Dahl, O; Klepp, O; Langberg, C; Laurell, A; Solberg, A; Stierner, U; Tandstad, T; Wijkstrøm, H | 1 |
Riese, MJ; Vaughn, DJ | 1 |
Akyol, I; Bilgi, O; Kandemir, EG; Karagoz, B; Ozgun, A; Turken, O | 1 |
Carver, BS; Sheinfeld, J | 1 |
Cagiannos, I; Morash, C | 1 |
Feldman, DR; Motzer, RJ | 1 |
Ito, N; Katsura, H; Kitahara, N; Kitaichi, M; Matsumura, A; Nakamura, Y; Ose, N; Sakaguchi, M | 1 |
Beyer, J; Bokemeyer, C; Dieing, A; Hackenthal, M; Hartmann, JT; Lorch, A; Neubauer, A; Rick, O | 1 |
de Wit, R; Sternberg, CN; Troost, MM | 1 |
Beyer, J; Bokemeyer, C; Kollmannsberger, C | 1 |
Akaza, H; Kawai, K | 1 |
Cappellano, AM; Cavalheiro, S; da Silva, NS; Diez, B; Finlay, J; Gardner, S; Garvin, J; Kellie, S; Parker, R; Wisoff, J | 1 |
Adamoli, L; Cossu Rocca, M; Curigliano, G; De Cobelli, O; De Pas, T; Fumagalli, L; Goldhirsch, A; Jereczek-Fossa, B; Locatelli, M; Lorizzo, K; Magni, E; Martinelli, G; Nolè, F; Spitaleri, G; Verri, E | 1 |
Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
Bains, M; Bajorin, DF; Bosl, GJ; Feldman, DR; Fischer, P; Ishill, N; Motzer, RJ; Patil, S; Reich, LM; Sheinfeld, J; Turkula, S | 1 |
Dhall, G; Fan, J; Finlay, JL; Gilles, F; Gonzalez, I; Jubran, R; Khatua, S; Krieger, M; Lavey, R; Marachelian, A; McComb, G; Nastia, A; Nelson, M; O'Neil, S; Olch, AJ; Panigrahy, A; Sposto, R; Villablanca, JG | 1 |
Arnold, D; Behlendorf, T; Jordan, K; Kegel, T; Mueller, LP; Schmoll, HJ; Sippel, C; Voigt, W; Wolf, HH | 1 |
Fukuda, H; Fukui, N; Higashi, Y; Hyochi, N; Ichiyanagi, N; Inoue, M; Ishioka, J; Kageyama, Y; Numao, N; Saito, K; Tanak, M | 1 |
Ishii, N; Matsuda, T; Morozumi, M; Takagi, D; Terao, T; Yamada, T; Yamashita, T; Yoshinaga, A | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Lorch, A; Rick, O; Wündisch, T | 1 |
Kollmannsberger, C; Nichols, C | 2 |
Boland, AL; Boyer, MJ; Craft, P; Gebski, VJ; Grimison, PS; Gurney, H; Harvey, VJ; Levi, JA; Lewis, CR; Olver, IN; Simes, RJ; Stockler, MR; Thomson, DB; Toner, GC | 1 |
Lin, CK; Liu, HT | 1 |
Alapetite, C; Baranzelli, MC; Ben-Hassel, M; Bernier, V; Bouffet, E; Brisse, H; Carrie, C; Cuilliere, JC; Frappaz, D; Gaboriaud, G; Habrand, JL; Patte, C; Raquin, MA; Thiesse, P | 1 |
Fujisawa, M; Miyake, H; Muramaki, M; Takenaka, A; Terakawa, T | 1 |
Aass, N; Bokemeyer, C; Collette, L; Daugaard, G; De Santis, M; De Wit, R; Dumez, H; Lluch, JRG; Marreaud, S; Schmoll, HJ; Skoneczna, I | 1 |
Abonour, R; Einhorn, LH; Kesler, KA | 1 |
Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y | 1 |
Abdel-Rahman, FA; Tuffaha, H | 1 |
Akaza, H; Bando, M; Itoh, K; Kawai, K; Kondo, Y; Nakayama, M; Saito, T; Sugiyama, Y | 1 |
Campbell, BA; Panicker, J | 1 |
Doi, M; Horimasu, Y; Kitaguchi, S; Kuwabara, M; Maeda, H; Ohe, M | 1 |
Bascoul-Mollevi, C; Beyer, J; De Giorgi, U; Einhorn, L; Fléchon, A; Germà-Lluch, JR; Kollmannsberger, C; Kramar, A; Lorch, A; Lotz, JP; Margolin, K; Massard, C; Necchi, A; Powles, T | 1 |
Anderson, H; Bremnes, RM; Cavallin-Ståhl, E; Cohn-Cedermark, G; Dahl, O; Jerkeman, M; Klepp, O; Langberg, CW; Laurell, A; Olofsson, SE; Solberg, A; Ståhl, O; Stierner, U; Tandstad, T; Wahlqvist, R; Wijkström, H | 1 |
Wolf, D; Wolf, R | 1 |
Arima, R; Kuratsu, J; Makino, K; Nakamura, H; Ushio, Y | 1 |
Asensio Vegas, A; Balandín Moreno, B; Cantos López de Ibargüen, B; Cuiñas León, K; Martínez Arrieta, F; Múñez Rubio, E; Ramos Martínez, A; Romero Pizarro, Y; Sánchez Romero, I | 1 |
Bakkali, YE; Hammoumi, ME; Kabiri, el H; Traibi, A | 1 |
Aksu, C; Başaran, M; Bavbek, S; Ekenel, M; Keskin, S; Kiliçaslan, I; Tunç, M | 1 |
Kawase, T; Takahashi, S; Yoshida, K | 1 |
Fainstein, I; Fedyanin, M; Garin, A; Kanagavel, D; Matveev, V; Polockij, B; Sergeev, J; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Bulanov, A; Burova, A; Fainshtein, I; Fedyanin, M; Figurin, K; Garin, A; Kanagavel, D; Sergeev, U; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Albers, P; Beyer, J; Lorch, A; Winter, C | 1 |
Armstrong, G; Chester, J; Joffe, J; Mazhar, D; Parashar, D; Powles, T; Rimmer, Y; Shamash, J; Stark, D; Wason, J; White, J; Williams, MV | 1 |
Cha, YJ; Kim, HR; Kim, JW; Park, EK; Yu, N | 1 |
Bremnes, RM; Cavallin-Ståhl, E; Cohn-Cedermark, G; Dahl, O; Haugnes, HS; Laurell, A; Stierner, U | 1 |
Aass, N; Albers, P; Collette, L; Daugaard, G; De Santis, M; de Wit, R; Garin, A; Germa-Lluch, JR; Marreaud, S; Skoneczna, I; White, JD; Witjes, AJ | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Kleinhans, A; Kollmannsberger, CK; Kramar, A; Lorch, A; Rick, O | 1 |
Daneshmand, S; Djaladat, H; Nichols, C | 1 |
Adachi, M; Aida, N; Hata, M; Inoue, T; Ito, S; Kigasawa, H; Niwa, T; Odagiri, K; Ogino, I; Omura, M | 1 |
Jayaram, L; Lee, L; Oppenheimer, R | 1 |
Lim, L; Powles, T; Rashid, S | 1 |
Başaran, M; Bavbek, S; Ekenel, M; Keskin, S | 1 |
Abonour, R; Brames, MJ; Einhorn, LH; Siddiqui, BK; Suleiman, Y | 1 |
Aslan, NM; Azrif, M; Fong, KV; Ismail, F; Leong, YK | 1 |
Cullen, M | 1 |
Carmichael, C; Ferrell, B; Frankel, P; Hsu, J; Margolin, K; Pal, SK; Saikia, J; Stein, CA; Sun, V; Twardowski, P; Yamzon, J | 1 |
Beyer, J; Droz, JP; Fizazi, K; Hartmann, JT; Kramar, A; Lorch, A; Massard, C; Pico, JL; Rosti, G | 1 |
Douchi, T; Kamio, M; Matsuo, T; Terao, S; Tsuji, T; Yanazume, S | 1 |
Fux-Arnold, C; Gavillet, M; Medinger, M; Tichelli, A | 1 |
Jaehde, U; Kloft, C; Lindauer, A; Nock, V | 1 |
Jaehde, U; Kloft, C; Minichmayr, I; Nock, V | 1 |
Kellie, SJ; Lockwood, L; Mauger, DC; Pozza, LD; Waters, KD; White, L; Wong, CK | 1 |
Atasalihi, A; Halezeroglu, S; Okur, E; Somay, A | 1 |
Bassetti, C; Lövblad, KO; Russmann, S; Stanga, Z; Winkler, A | 1 |
Ozen, H; Uygur, MC | 1 |
Borges, LR; Dzik, C; Gabbai, AA; Malheiros, SM; Nalli, DG; Santos, AJ | 1 |
Badenoch, D; Berney, D; Nargund, V; Oliver, RT; Ong, J; Shamash, J | 1 |
Billmire, D; Colombani, P; Cullen, J; Cushing, B; Davis, M; Giller, R; Hawkins, E; Lauer, S; London, W; Rescorla, F; Vinocur, C | 1 |
Cowlishaw, D; McKendrick, JJ; Mead, GM | 1 |
Aass, N; Alfsen, GC; Fossa, SD; Lien, HH; Oldenburg, J; Waehre, H | 1 |
Einhorn, LH; Foster, RS; Henley, JD; Sheski, FD | 1 |
Alken, P; Häcker, A; Hatzinger, M; Knoll, T; Köhrmann, KU; Michel, MS; Siegsmund, M | 1 |
Christodoulou, J; Haferlach, T; Schnittger, S; Schoch, C | 1 |
Anthoney, DA; Graham, J; Hutcheon, AW; Jones, W; Kaye, SB; McKean, MJ; Paul, J; Roberts, JT | 1 |
Komoda, K; Oka, T; Shiina, Y | 1 |
Aoki, N; Fukui, I; Ishikawa, Y; Maezawa, T; Nakagawa, K; Nakaishi, M; Ohkubo, Y; Okumura, S; Sakura, M; Takimoto, K; Tsukamoto, T; Yonese, J | 1 |
Billmire, DF; Castleberry, RP; Colombani, P; Cullen, JW; Cushing, B; Davis, MM; Giller, R; Hawkins, EP; Lauer, SJ; London, WB; Marina, NM; Olson, TA; Perlman, EJ; Rescorla, F; Rogers, PC; Vinocur, CD | 1 |
Akamatsu, S; Inoue, K; Nishio, Y; Tsukazaki, H | 1 |
Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L | 1 |
Biron, P; Bui, B; Caty, A; Culine, S; Curé, H; De Revel, T; Delva, R; Droz, JP; Duclos, B; Fizazi, K; Gligorov, J; Gomez, F; Gravis, G; Guillemaut, S; Lotz, JP; Peny, J; Provent, S; Ségura, C; Théodore, C; Viens, P | 1 |
Chaudhary, UB; Damon, LE; Linker, CA; Navarro, W; Rugo, HS; Small, EJ | 1 |
Fujinami, K; Miura, T; Osada, Y; Takizawa, A | 1 |
Biron, P; Bouzy, J; Droz, JP; Horwich, A; Koza, V; Kramar, A; Lelli, G; Linkesch, W; Marangolo, M; Pico, JL; Pizzocaro, G; Rosti, G; Salvioni, R; Schmoll, HJ; Siegert, W; Theodore, C; Wandt, H | 1 |
Debes, A; Göbel, U; Wessalowski, R; Willers, R | 1 |
Miranda, P; Ramos, A; Ricoy, JR | 1 |
Farmakis, D; Pectasides, D; Pectasides, M | 1 |
Cook, PA; Cullen, MH; Harper, P; Huddart, R; Mason, M; Mead, GM; Rustin, GJ; Stenning, SP | 1 |
Billmire, DF; Chang, KW; Davis, MM; Frazier, AL; Giller, R; Lauer, SJ; London, WB; Malogolowkin, M; Marina, N; Olson, TA; Perlman, EJ; Rescorla, F; Womer, RB | 1 |
Takahashi, H; Tanaka, R | 1 |
Jordan, K; Kegel, T; Maher, G; Müller, L; Schmoll, HJ; Voigt, W | 1 |
Axtell, RA; Boyett, JM; Breiger, D; Broxson, E; Donahue, B; Finlay, JL; Geyer, JR; Goldwein, JW; Heier, LA; Jennings, M; Johnson, D; Mazewski, C; Miller, DC; Packer, R; Puccetti, D; Radcliffe, J; Shiminski-Maher, T; Sposto, R; Tao, ML | 1 |
Collette, L; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Horwich, A; Kaiser, G; Koriakine, O; Paluchowska, B; van Oosterom, AT | 1 |
Rexer, FH | 1 |
Alvarnas, J; Chow, W; Doroshow, JH; Frankel, P; Kogut, N; Leong, LA; Lim, D; Margolin, KA; McNamara, M; Morgan, RJ; Schriber, J; Shibata, S; Somlo, G; Stalter, S; Twardowski, P; Yen, Y | 1 |
Managadze, L; Mezvrishvili, Z | 2 |
Bacik, J; Bajorin, D; Bosl, GJ; Dobrzynski, D; Kondagunta, GV; Motzer, RJ; Sheinfeld, J | 1 |
Fujinami, K; Maruta, I; Miura, T; Osada, Y; Takizawa, A; Tanaka, M | 1 |
De Giorgi, U; Rosti, G | 1 |
Burger, P; Greenberg, M; Holmes, E; Kleinberg, L; Kretschmar, C; Wharam, M | 1 |
Braat, DD; Kiemeney, LA; Ramos, L; Spermon, JR; Sweep, CG; Wetzels, AM; Witjes, JA | 1 |
Classen, J; Dieckmann, KP; Gertenbach, U; Hahn, E; Loy, V; Ruwe, M; Souchon, R; Stambolis, C | 1 |
Fukumori, T; Harada, A; Izaki, H; Kanayama, HO; Katto, K; Kishimoto, T; Nakatuji, Y; Nishitani, M; Oka, N; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
Einhorn, LH; Foster, RS | 1 |
Dearnaley, DP; Gilbert, DC; Horwich, A; Huddart, RA; Nicholl, J; Norman, AR | 1 |
Goto, S; Kanda, T; Nakagomi, K; Torizuka, T | 1 |
Fukumori, T; Harada, A; Hayashi, H; Izaki, H; Kanayama, HO; Kishimoto, T; Nishitani, MA; Takahashi, M; Tanimoto, S; Taue, R; Yamamoto, Y | 1 |
Fujisawa, M; Furukawa, J; Hara, I; Kumano, M; Miyake, H; Takenaka, A; Yamada, Y; Yamanaka, K | 1 |
Akaza, H; Hasegawa, Y; Hattori, K; Hinotsu, S; Kawai, K; Kojima, H; Miyanaga, N; Oikawa, T; Sekido, N; Shimazui, T | 1 |
Alloisio, M; Banna, GL; Castagna, L; De Giorgi, U; Ferrari, B; Marangolo, M; Rosti, G; Santoro, A | 1 |
Biron, P; Bouzy, J; Chevreau, C; Culine, S; Curé, H; Droz, JP; Kerbrat, P; Kramar, A; Pény, J; Pico, JL; Théodore, C | 1 |
Kondagunta, GV; Motzer, RJ | 2 |
Huang, ZH; Ling, JY; Sun, XF; Xia, Y; Yang, QY; Zhen, ZJ | 1 |
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Budnick, A; Deluca, J; Ishill, N; Kondagunta, GV; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J | 1 |
Akaza, H; Hara, I; Miki, T; Mizutani, Y; Naito, K; Nonomura, N; Ozono, S; Terachi, T; Tsukamoto, T; Yoshida, O | 1 |
Bacik, J; Bajorin, DF; Bosl, GJ; Einhorn, L; Lara, PN; Margolin, KA; Mazumdar, M; Motzer, RJ; Nichols, CJ; Richardson, PG; Vogelzang, NJ | 1 |
Cartner, M; Holley, A; Lipman, J | 1 |
Biron, P; Bouzy, J; Bui, NB; Caty, A; Chevreau, C; Culine, S; Delva, R; Droz, JP; Fizazi, K; Geoffrois, L; Kerbrat, P; Kramar, A; Pény, J; Théodore, C | 1 |
Brozmanová, K; Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Risnyovzská, Z; Sálek, T; Svetlovská, D; Sycová-Milá, Z | 1 |
Culine, S | 1 |
Fizazi, K; Loriot, Y | 1 |
Li, J; Wu, X; Yang, W | 1 |
Vaughn, DJ | 1 |
Droz, JP; Fléchon, A | 1 |
Ebisawa, S; Fujimoto, K; Hanaoka, M; Koizumi, T; Kubo, K; Tsushima, K; Urushihata, K; Yamazaki, S; Yasuo, M | 1 |
Sleijfer, S | 1 |
Chang, CH; Chen, KC; Chen, YH; Chu, CC; Diau, GY; Loh, IW | 1 |
Berdel, WE; Beyer, J; Bokemeyer, C; Egerer, G; Haas, A; Hartmann, JT; Kollmannsberger, C; Lorch, A; Metzner, B; Rick, O; Schirren, R; Schleicher, J; Schmidt-Wolf, IG; Weissinger, F | 1 |
Ansell, W; Asterling, S; Berney, D; Joel, SP; Liu, S; Mutsvangwa, K; Oliver, RT; Powles, T; Shamash, J; Stebbing, J; Wilson, P; Wyatt, P | 1 |
Abonour, R; Brames, MJ; Chamness, A; Einhorn, LH; Perkins, SM; Williams, SD | 1 |
Azar, JM; Einhorn, LH; Schneider, BP | 1 |
Krege, S; Rübben, H; vom Dorp, F | 1 |
Albers, P; Langenkamp, S | 1 |
de Wit, R | 1 |
Marwaha, S; North, SA; Venner, PM | 1 |
Galsky, MD; Kondagunta, V; Sonpavde, G | 1 |
Chang, TK; Chen, HC; Chi, CS; Chou, G; Shu, SG; Wang, JD; Yang, CS | 1 |
Fey, MF; Karamitopoulou-Diamantis, E; Schefer, H; Studer, UE; Thalmann, GN; Westermann, DH | 1 |
Bai, CM; Chen, SC; Yang, D; Zhou, JF | 1 |
Bell, S; Doolittle, ND; Fortin, D; Jahnke, K; Knight, KR; Kraemer, DF; Muldoon, LL; Neuwelt, EA | 1 |
Beyer, J; Bokemeyer, C; Casper, J; Derigs, G; Gauler, T; Gerl, A; Hartmann, JT; Horger, M; Kuczyk, MA; Mayer-Steinacker, R; Metzner, B; Rick, O; Schleicher, J | 1 |
Addla, SK; Clarke, NW; Dunham, MP; Grey, BR; Ramani, VA; Sangar, VK | 1 |
Biron, P; Bouzy, J; Caty, A; Chevreau, C; Culine, S; Delva, R; Droz, JP; Fargeot, P; Fizazi, K; Geoffrois, L; Héron, JF; Kerbrat, P; Kramar, A; Nguyen, BB; Théodore, C | 1 |
Fujisawa, M; Hara, I; Kumano, M; Miyake, H; Muramaki, M; Takenaka, A | 1 |
Hospers, GA; Rutgers, B; Verdonk, RC | 1 |
Hussain, A; Tummala, MK | 1 |
Bokemeyer, C | 1 |
Boezen, HM; de Haas, EC; Gietema, JA; Hoekstra, HJ; Meijer, C; Nuver, J; Sleijfer, DT; Suurmeijer, AJ; van der Steege, G; Zwart, N | 1 |
Bosl, GJ; Feldman, DR; Ishill, N; Jathavedam, A; Motzer, RJ; Patil, S; Turkula, S; Weinstock, DM | 1 |
Cai, QQ; Huang, HQ; Ling, JY; Sun, XF; Xia, Y; Yang, QY; Zhen, ZJ | 1 |
Motzer, RJ; Sheinfeld, J | 1 |
Albers, P; Dieckmann, KP; Fimmers, R; Hartmann, M; Heidenreich, A; Kliesch, S; Köhrmann, KU; Krege, S; Kwasny, P; Lehmann, J; Loy, V; Pechoel, M; Schmelz, HU; Siener, R; Weissbach, L; Wittekind, C | 1 |
de Vries, EG; De Vries-Hospers, HG; Holthuis, JJ; Mulder, NH; Postmus, PE; Sibinga, CT; Sleijfer, DT; van Imhoff, GW; Vriesendorp, R | 1 |
Jacobsen, M; Nissen, MH; Olsen, J; Rørth, M; Vindeløv, L | 1 |
De Vries, EG; Meinesz, AF; Mulder, NH; Orie, JL; Postmus, PE; Sleijfer, DT; Van der Geest, S; Vriesendorp, R | 1 |
Barrett, A; Dobbs, HJ; Hendry, WF; Horwich, A; Liew, KH; McElwain, TJ; Peckham, MJ; Robinson, B | 1 |
Barrett, A; Calvo, F; Hodson, N; Peckham, MJ | 1 |
Donohue, JP; Einhorn, LH; Kamer, M; Rowland, RG | 1 |
Bagshawe, KD | 1 |
Bukowski, RM; Hewlett, JS; Livingston, RB; Montie, J; Mortimer, J | 1 |
Einhorn, LH; Williams, SD | 1 |
Greco, FA; Johnson, DH; Wolff, SN | 1 |
Canellos, GP; Garnick, MB; Lederman, GS; Richie, JP | 1 |
Bosl, GJ; Dukeman, M; Golbey, R; Herr, H; Sogani, P; Vugrin, D; Whitmore, WF; Yagoda, A | 1 |
Broun, ER; Einhorn, LH; Lazarus, HM; Loehrer, PJ; Nichols, CR; Roth, BJ; Turns, M; Williams, SD | 1 |
Abratt, RP; Barnes, RD; Pontin, AR; Reddi, BV | 1 |
Chang, TK; Hwang, B; Wong, TT | 1 |
Bourhis, JH; Droz, JP; Fadel, E; Ibrahim, A; Pico, JL | 1 |
de Vries, EG; Groenewegen, A; Kema, IP; Schröder, CP; Sleijfer, DT; van der Graaf, WT | 1 |
Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C | 1 |
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW | 1 |
Breeden, ES; Einhorn, LH; Loehrer, PJ; Nichols, CR; Williams, SD | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
Germá, JR; Izquierdo, MA; Sagarra, AF; Seguí, MA | 1 |
Balbay, MD; Bekdik, C; Caner, B; Ozen, HA; Remzi, D; Ugur, O; Ulutuncel, N | 1 |
Blayney, DW; Burke, JS; Doroshow, JH; Goldberg, DA; Leong, LA; Margolin, KA | 1 |
Blumenstein, B; Bukowski, RM; Crawford, ED; Kulander, BG; Montie, J; Wolf, M | 1 |
Kobayashi, T; Matsutani, M; Nagai, H; Shitara, N; Sugita, K; Takakura, K; Tanaka, R; Yamada, H; Yamashita, J; Yoshida, J | 1 |
Blake, KI; Gerrard, MP | 1 |
Hansen, LJ; Madsen, EL; Møller, MN | 1 |
Hosaka, M; Ikeda, I; Kubota, Y; Shuin, T; Yao, M | 1 |
Goepel, M; Otto, T; Rübben, H; Seeber, S | 1 |
Einhorn, LH | 4 |
Calderoni, A; Fey, MF; Kraft, R; Mazzucchelli, L; Sonntag, RW; Studer, UE | 1 |
Clemm, C; Gerl, A; Hartenstein, R; Hentrich, M; Wilmanns, W | 1 |
Boutan-Laroze, A; Chazard, M; Culine, S; Droz, JP; Kattan, J; Kramar, A; Mahjoubi, M | 1 |
de Veber, LL; Del Maestro, RF; Ramsay, DA; Sahjpaul, RL | 1 |
Bajorin, DF; Fair, WR; Geller, NL; Herr, H; Mazumdar, M; Motzer, RJ; Pfister, DG; Sarosdy, MF; Scher, HI; Sogani, P | 1 |
Droz, JP; Kramar, A; Pico, JL | 1 |
Bosl, GJ; Gulati, SC; Lin, S; Lyn, P; Mazumdar, M; Menendez-Botet, C; Motzer, RJ; Tong, WP; Vlamis, V | 1 |
Barnett, MJ; Coppin, CM; Klingemann, HG; Murray, N; Nantel, SH; Nevill, TJ; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
Angioni, A; Boglino, C; Cozza, R; Deb, G; Donfrancesco, A; Helson, L; Jenkner, A; Landolfo, A; Maurizio, C | 1 |
Dam-Meiring, A; de Vries, EG; Guchelaar, HJ; Mulder, NH; Oosterhuis, JW; Timmer-Bosscha, H; Uges, DR | 1 |
Dieckmann, KP; Loy, V | 1 |
Broun, ER; Cornetta, K; Einhorn, LH; Hromas, R; Mandanas, R; Nichols, CR; Salzman, D; Turns, M | 1 |
Baki, M; Bodrogi, I; Eckhardt, S; Géczi, L; Hindy, I; Horti, J; Liszka, G; Ottó, S; Sugár, J | 1 |
Biron, P; Droz, JP | 1 |
Beckert, R; Pust, RA; Sparwasser, C; Treiber, U | 1 |
Doughty, D; Kingston, JE; Plowman, PN; Sebag-Montefiore, D | 1 |
Court, BH; Culine, S; Droz, JP; Perrin, JL; Theodore, C | 1 |
Bekradda, M; Culine, S; Droz, JP; Farhat, F; Terrier-Lacombe, MJ; Théodore, C | 1 |
Ellison, DW; Katapodis, O; Mead, GM; O'Callaghan, AM; Theaker, JM | 1 |
Ikeda, K; Ikeda, T; Kawakami, K; Sasaki, K; Takahara, J | 1 |
Frohmüller, H; Hofmockel, G; Langer, W; Will, R | 1 |
Bakker, PJ; de Mulder, PH; de Vries, EG; de Wit, R; Keizer, HJ; Kooi, M; Lalisang, RI; Mandjes, I; Rodenhuis, S; Sleijfer, DT | 1 |
Decatris, MP; Dougall, M; Metzner, M; Morgenstern, GR; Welch, RS; Wilkinson, PM | 1 |
Bamberg, M; Beyer, J; Böhlke, I; Bokemeyer, C; Derigs, G; Hartmann, JT; Kanz, L; Kollmannsberger, C; Nichols, C; Rüther, U; Schleucher, N; Schmoll, HJ; Schöfski, P | 1 |
Hattori, T; Imamura, T; Ito, T; Nakamura, K; Obana, K; Ogawa, B; Okinaga, K; Tanaka, F; Yanagawa, Y | 1 |
Gallagher, CJ; Gupta, RK; Kelsey, S; Lister, TA; Newland, AC; O'Doherty, CA; Oliver, RT; Shamash, J | 1 |
Billmire, D; Colombani, P; Cullen, J; Cushing, B; Davis, M; Giller, R; Hawkins, E; Krailo, M; Lauer, S; Rescorla, F; Shuster, J; Stolar, C; Vinocur, C | 1 |
Billmire, D; Colombani, P; Cushing, B; Giller, R; Hawkins, E; Lauer, S; London, WB; Rescorla, F; Vinocur, C | 1 |
Ambros, PF; Blohm, ME; Bolkenius, M; Calaminus, G; Gnekow, AK; Göbel, U; Harms, D; Heidemann, PH; Schneider, DT; von Schweinitz, D; Weinel, P | 1 |
Collette, L; Cook, P; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Mead, GM; Roberts, JT; Stenning, S; Wilkinson, PM | 1 |
Adams, PT; Ayash, LJ; Braun, T; Broun, ER; Clarke, M; Ferrara, J; Ratanatharathorn, V; Reynolds, C; Silver, SM; Uberti, J | 1 |
Beyer, J; Huhn, D; Kingreen, D; Kleiner, S; Reif, S; Siegert, W | 1 |
Fukuyama, T; Hishizawa, M; Ichinohe, T; Ito, N; Kakehi, Y; Kamato, T; Kobayashi, T; Nakamura, E; Ogawa, O; Yamamoto, S | 1 |
Cooke-Yarborough, C; Martin, HC; Onikul, E; Sharathkumar, A; Shaw, PJ | 1 |
Bokemeyer, C; Fonatsch, C; Freund, M; Rieder, H; Schmoll, HJ | 1 |
Douek, E; Kingston, JE; Plowman, PN; Sebag-Montefiore, DJ | 1 |
Ihara, H; Ikoma, F; Iwasaki, A; Mori, Y; Shima, H; Yabumoto, H; Yoshioka, M | 1 |
Crown, JP; Doherty, M; Fair, W; Gulati, SC; Herr, H; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Weisen, S | 1 |
Andersen, J; Fisher, H; Greer, J; Lazarus, HM; Loehrer, PJ; Nichols, CR; Stadtmauer, EA; Trump, DL | 1 |
Hotta, T; Kiya, K; Kurisu, K; Mikami, T; Ogasawara, H; Sugiyama, K; Uozumi, T | 1 |
Faustini, M; Gianni, L; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R | 1 |
Doughty, D; Plowman, PN; Sebag-Montefiore, DJ | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ; Vlamis, V; Weisen, S | 1 |
Loehrer, PJ | 3 |
Nichols, CR | 1 |
Beyer, J; Grabbe, J; Huhn, D; Lenz, K; Siegert, W; Strohscheer, I; Weisbach, V | 1 |
Einhorn, LH; Lester, SG; Morphis, JG; Spears, WT; Williams, SD | 1 |
Saxman, S | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ | 1 |
Hartmann, M; Holstein, AF; Lauke, H; Mumperow, E | 1 |
Peters, NH; Price, BA | 1 |
Alonso, C; Climent, MA; Germá, JR; Izquierdo, MA; Ojeda, B; Seguí, MA | 1 |
Chambers, JT; Chambers, SK; Kohorn, E; McIntosh, S; Schwartz, PE | 1 |
Fraley, EE; Gonzalez-Vela, JL; Kennedy, BJ; Torkelson, JL; Villalona-Calero, MA | 1 |
Berruti, A; Borasio, P; Dogliotti, L; Gorzegno, G; Mossetti, C; Pazè, E | 1 |
Daugaard, G; Rørth, M | 1 |
Childs, WJ; Horwich, A; Nicholls, EJ | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH | 2 |
Hatae, M; Hokanishi, H; Kume, H; Maeda, Y; Nakagawa, S; Onishi, Y | 1 |
Bruun, B; Daugaard, G; Nielsen, H; Tvede, M | 1 |
Broun, ER; Einhorn, LH; Loehrer, PJ; Nichols, CR; Tricot, G; Williams, SD | 1 |
Greer, JP; Lukens, JN; Whitlock, JA | 1 |
Bokemeyer, C; Bruderek, L; Casper, J; Harstrick, A; Köhne-Wömpner, CH; Schmoll, E; Schmoll, HJ; Schöber, C; Stahl, M; Wilke, H | 1 |
Albertazzi, L; Bassetto, MA; Marangolo, M; Pizzocaro, G; Rosti, G; Salvioni, R; Valzania, F | 1 |
Broun, ER; Einhorn, LH; Nichols, CR; Tricot, GJ | 1 |
Berdel, W; Bokemeyer, C; Harstrick, A; Illiger, HJ; Manegold, C; Metzner, B; Ostermann, H; Räth, U; Schmoll, HJ; Siegert, W | 1 |
Höltl, W; Honetz, N; Julcher, H; Kienzer, H; Kosak, D; Machacek, E; Pont, J | 1 |
Hagiwara, M; Iinuma, S; Nakazono, M; Yamamoto, H | 1 |
Cangir, A; Edwards, CL; Gershenson, DM; Kavanagh, JJ; Morris, M; Silva, EG; Stringer, CA; Wharton, JT | 1 |
Barnes, JM; Barrett, A; Gornall, P; Huddart, SN; Mann, JR; Pearson, D; Raafat, F; Wallendsus, KR | 1 |
Bajorin, D; Cooper, K; Fair, W; Geller, NL; Herr, H; Lin, SY; Morse, M; Motzer, RJ; Pfister, DG; Scher, HI | 1 |
Aass, N; Blomlie, V; Fosså, SD; Ous, S; Saeter, G; Stenwig, AE | 1 |
Castañeda, VL; Geiser, CF; Marlin, AE; Mullins, JK; Parmley, RT; Saldivar, VA | 1 |
Bliss, JM; Hogan, SJ; Horwich, A; Price, P | 1 |
Harvey, V; Levi, J; Raghavan, D; Thomson, D | 1 |
Broadbent, V; Horwich, A; Levitt, J; McElwain, TJ; Meller, ST; Mott, M; Oakhill, A; Pinkerton, CR; Pritchard, J | 1 |
Bosl, GJ; Geller, NL; Motzer, RJ | 1 |
Gonzalez-Vela, JL; Kennedy, BJ; Manivel, JC; Savage, PD; Torkelson, JL | 1 |
Itoyama, Y; Kochi, M; Kuratsu, J; Uemura, S; Ushio, Y; Yamamoto, H | 1 |
Daugaard, G; Hansen, HH; Rørth, M | 1 |
Dearnaley, DP; Harland, S; Hendry, WF; Horwich, A; Jay, G; Mason, M; Nicholls, J; Peckham, MJ | 1 |
Altman, SJ; Blumenstein, BA; Bouroncle, BA; Crawford, ED; Ford, CD; Natale, RB; Samson, MK; Shah, NT; Stephens, RL; Wozniak, AJ | 1 |
Bosl, GJ; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sheinfeld, J; Sogani, P; Tan, CC | 1 |
Jost, LM; Pichert, G; Stahel, RA | 1 |
Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W | 1 |
Bartolucci, A; Crawford, ED; Einhorn, LH; Greco, FA; Loehrer, PJ; Miller, ME; Nichols, CR; Schacter, L; Weetlaufer, J; Williams, SD | 1 |
Eber, B; Greinix, H; Lind, P; Schwarzer, S | 1 |
Daugaard, G; Hansen, SW; Larsen, SO; Pedersen-Bjergaard, J; Philip, P; Rørth, M | 1 |
Goya, T; Hayashi, M; Kondo, H; Ohira, M; Ohkura, H; Shimada, Y; Shimoyama, M; Takayama, J; Tobinai, K; Tobisu, K | 1 |
Baume, D; Beaujean, F; Droz, JP; Ghosn, M; Gouyette, A; Hayat, M; Ostronoff, M; Pico, JL; Piot, G; Theodore, C | 1 |
Fox, EP; Loehrer, PJ | 1 |
Ando, M; Fukui, I; Goto, S; Hagiwara, T; Kihara, K; Kitahara, S; Noro, A; Toyoshima, T; Tsujii, T; Tsukamoto, T | 1 |
Grimes, D; Thomson, DB; Walpole, ET | 1 |
Bajorin, DF; Bosl, GJ; Geller, NL; Weisen, SF | 1 |
Gilsanz, V; Isaacs, H; Laug, W; Ortega, JA; Ozkaynak, MF | 1 |
Burns, I; Byrne, M; Gill, G; Harvey, V; Levi, JA; Raghavan, D; Sandeman, T; Snyder, R; Tattersall, M; Thomson, D | 1 |
Douglass, EC; Etcubanas, EE; Fairclough, DL; Horowitz, ME; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JW; Mulhern, RK; Sanford, RA | 1 |
Binet, C; Chazard, M; Colombat, P; Desbois, I; Haillot, O; Lamagnere, JP; Linassier, C; Reisenleiter, M | 1 |
Einhorn, LH; Miller, JC | 1 |
Azab, M; Baume, D; Beaujean, F; Droz, JP; Ghosn, M; Gilles, E; Gouyette, A; Ostronoff, M; Pico, JL; Salloum, E | 1 |
Vogelzang, NJ | 1 |
Bajorin, DF; Cooper, K; Dmitrovsky, E; Fair, W; Geller, NL; Herr, H; Morse, M; Motzer, RJ; Russo, P; Sogani, P | 1 |
Isaka, S; Ishii, H; Okano, T; Osa, Y; Shimazaki, J; Yasuda, K | 1 |
Hamaguchi, K; Harataka, J; Nagasue, N; Nishimura, H; Okura, N; Yakushiji, M | 1 |
Blackmore, C; Hendry, WF; Horwich, A; Peckham, MJ | 1 |
Anderson, RW; Kennedy, BJ; Vogelzang, NJ | 1 |
de Góes, GM; Simon, SD; Srougi, M | 1 |
Milani, A; Pasi, M; Piva, L; Pizzocaro, G; Salvioni, R; Zanoni, F | 1 |
Milani, A; Piva, L; Pizzocaro, G; Salvioni, R; Zanoni, F | 1 |
Pinkerton, CR; Pritchard, J; Spitz, L | 1 |
Pizzocaro, G | 1 |
Stoter, G | 1 |
Bagshawe, KD; Begent, RH; Crawford, SM; Newlands, ES; Rustin, GJ | 2 |
Bassoulet, J; Garetta, L; Raoul, Y | 1 |
Clark, S; Donohue, JP; Einhorn, LH; Hui, S; Loehrer, PJ; Mandelbaum, I; Rowland, R; Seal, M; Ulbright, T; Williams, SD | 1 |
Doll, DC; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; List, AF | 1 |
Bagshawe, KD; Begent, RH; Crawford, SM; Holden, L; Newlands, ES; Rustin, GJ | 2 |
Daugaard, G; Rŗth, M | 1 |
Aas, M; Fosså, SD; Hall, KS | 1 |
Garnick, MB; Lederman, GS | 1 |
Daugaard, G; Hansen, SW; Rørth, M | 1 |
Auman, J; Bosl, GJ; Carey, R; Chan, E; Geller, NL; Herr, H; Morse, M; Sogani, P; Vogelzang, NJ; Whitmore, WF | 1 |
Birch, R; Einhorn, LH; Greco, FA; Irwin, L; Loehrer, PJ; Williams, SD | 1 |
Bagshawe, KD; Begent, RH; Newlands, ES; Pektasides, D; Rustin, GJ | 2 |
Brada, M; Horwich, A; Peckham, MJ | 1 |
Ozols, RF | 2 |
Atlas, SA; Bosl, GJ; Leitner, SP; Preibisz, JJ; Scheiner, E; Sealey, JE | 1 |
Bajorunas, D; Bosl, GJ | 1 |
Peckham, MJ; Smales, E | 1 |
Bergmann, KA | 1 |
Carter, GE; Daniels, JR; Lieskovsky, G; Skinner, DG | 1 |
Imanaka, K; Kondo, N; Machida, T; Yamazaki, H; Yuichiro, A | 1 |
Goldstraw, P; Kay, PH; Wells, FC | 1 |
Dawson, NA; Knight, RD; McLeod, DG; Skoog, SJ; Taylor, HG; Waxman, JA | 1 |
Tiuliandin, SA | 1 |
Bukowski, RM; Montie, JE; Smith, GW | 1 |
Ihde, DC; Jacob, J; Linehan, WM; Ostchega, Y; Ozols, RF; Young, RC | 1 |
Ihde, DC; Linehan, WM; Ozols, RF; Young, RC | 1 |
Auman, J; Bajorin, D; Bosl, GJ; Carey, R; Geller, NL; Golbey, RB; Leitner, SP; Scher, H; Vogelzang, NJ; Yagoda, A | 1 |
Clarke, J; Cullen, MH; Harper, PG; Kirkbride, P; Woodroffe, CM | 1 |
Birch, R; Drasga, R; Einhorn, LH; Greco, FA; Loehrer, PJ; Omura, G; Williams, SD | 1 |
Bagshawe, KD; Begent, RH; Hitchins, RN; Newlands, ES; Rustin, GJ; Smith, DB | 1 |
Barnes, JM; Barrett, A; Mann, JR; Pearson, D; Raafat, F; Wallendszus, KR | 1 |
Brada, M; Dearnaley, D; Hendry, WF; Horwich, A; Jay, G; Nicholls, J; Peckham, MJ | 1 |
Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D | 1 |
Bush, C; Delic, JI; Schlappack, OK; Steel, GG | 1 |
Damstrup, L; Daugaard, G; Gerstoft, J; Rørth, M | 1 |
Green, JA; Hammond, P; Watkin, SW | 1 |
Emoto, K; Kodama, Y; Onda, J; Uozumi, T; Yukawa, O; Yuki, K | 1 |
Einhorn, LH; Loehrer, PJ; Williams, SD | 1 |
Ishiyama, J; Kida, Y; Kito, A; Kobayashi, T; Noda, S; Yoshida, J | 1 |
Akard, L; Goulet, R; Hoffman, R; Loehrer, PJ; Nichols, CR; Roth, BJ; Tricot, G; van Besien, K; Williams, SD; Wolff, SN | 1 |
Azab, M; Droz, JP; Ghosn, M; Guimares, J; Mahjoubi, M; Moran, A; Ostronoff, M; Pico, J; Ribrag, V; Theodore, C | 1 |
Bodrogi, I | 1 |
Newlands, ES | 1 |
Birch, R; Einhorn, LH; Greco, FA; Hainsworth, JD; Williams, SD | 1 |
Baume, D; Deniel, A; Droz, JP; Gouyette, A; Hayat, M; le Bail, N; Ostronoff, M; Pico, JL | 1 |
de Vries, EG; Koops, HS; Maas, A; Mulder, NH; Mulder, PO; Sleijfer, DT; Splinter, T; van der Geest, S | 1 |
Einhorn, LH; Kalasinski, LA; Lauer, R; Loehrer, PJ; Roth, BJ; Williams, SD | 1 |
Nagasue, N; Nishida, T; Obuchi, T; Sasaki, T; Yakushiji, M | 1 |
Bosl, GJ; Golbey, RB; Herr, H; MacDonald, G; Morse, M; Sogani, P; Vogelzang, N; Whitmore, W; Yagoda, A | 1 |
Hortvet, L; Trump, DL | 1 |
Glatte, P; Osieka, R; Pannenbäcker, R; Schmidt, CG; Seeber, S; Soll, D | 1 |
Blessing, JA; Christopherson, WA; DiSaia, PJ; Slayton, RE | 1 |
57 review(s) available for etoposide and Cancer, Embryonal
Article | Year |
---|---|
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2022 |
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; COVID-19; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; RNA, Viral; SARS-CoV-2; Testicular Neoplasms | 2022 |
High-dose chemotherapy for relapsed testicular germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2023 |
Malignant germ cell tumor of fallopian tube with rhabdomyosarcoma: a case report and literature review.
Topics: Abdominal Pain; Adult; Etoposide; Fallopian Tubes; Female; Humans; Neoplasms, Germ Cell and Embryonal; Rhabdomyosarcoma | 2023 |
[Extragonadal germ cell tumor: A case report and review of the literature].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2022 |
Placental Site Trophoblastic Tumor in Nonseminomatous Mixed Germ Cell Tumors of the Testis: a Case Report and Review of the Literature.
Topics: Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Pregnancy; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Trophoblastic Tumor, Placental Site | 2018 |
Current medical management of patients with poor-risk metastatic germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Taxoids; Testicular Neoplasms | 2018 |
Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Retroperitoneal Space; Seminoma; Testicular Neoplasms | 2018 |
Current pharmacotherapy for testicular germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Testicular Neoplasms | 2019 |
Current Management of Disseminated Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Practice Guidelines as Topic; Prognosis; Testicular Neoplasms | 2019 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
The role of high-dose chemotherapy in the management of germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy | 2014 |
Management of stage I testicular germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Practice Guidelines as Topic; Radiotherapy, Adjuvant; Testicular Neoplasms | 2016 |
High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Patient Selection; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2017 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Transplantation, Autologous | 2017 |
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Topics: alpha-Fetoproteins; Carboplatin; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Follow-Up Studies; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Supratentorial Neoplasms; Testicular Neoplasms; Young Adult | 2008 |
Chemotherapy for patients with poor prognosis germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vinblastine | 2009 |
Management of post-chemotherapy extra-retroperitoneal residual masses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms | 2009 |
Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms | 2009 |
Management of good risk germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors; Testicular Neoplasms | 2009 |
High-dose chemotherapy in nonseminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome; Vindesine | 2009 |
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Salvage Therapy; Testicular Neoplasms | 2010 |
First-line chemotherapy of disseminated germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2011 |
[Clostridium difficile enteritis].
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clostridioides difficile; Combined Modality Therapy; Enteritis; Enterocolitis, Pseudomembranous; Etoposide; Gastrostomy; Humans; Ileostomy; Intestinal Obstruction; Male; Multiple Organ Failure; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Opportunistic Infections; Orchiectomy; Postoperative Complications; Spain; Superinfection; Testicular Neoplasms | 2011 |
[High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Seminoma; Testicular Neoplasms; Young Adult | 2011 |
Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Therapeutic Equipoise | 2012 |
[Ischemic stroke after chemotherapy with cisplatin, etoposide and bleomycin: case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Ischemia; Cisplatin; Etoposide; Germinoma; Humans; Male; Neoplasms, Germ Cell and Embryonal; Stroke; Testicular Neoplasms | 2003 |
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 2003 |
[The result of VIP chemotherapy as an induction therapy in 6 patients with non-seminomatous extragonadal germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies | 2004 |
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2005 |
[Chemotherapy for brain tumor].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Delivery Systems; Etoposide; Humans; Lymphoma; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Nimustine; Oligodendroglioma; Platinum Compounds; Randomized Controlled Trials as Topic; Vincristine | 2005 |
High dose chemotherapy in germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Patient Selection; Prognosis; Risk Factors; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
Chemotherapy for advanced germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Palliative Care; Randomized Controlled Trials as Topic; Salvage Therapy | 2006 |
[Management of localized germ-cell tumours of the testis].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Seminoma; Testicular Neoplasms; Testis; Time; Time Factors | 2007 |
Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Risk Assessment; Testicular Neoplasms; Treatment Outcome | 2007 |
Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Space; Testicular Neoplasms; Treatment Outcome | 2007 |
[Testis germ cell tumours: which chemotherapy, for which patients?].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Seminoma; Testicular Neoplasms; Testis; Vinblastine | 2007 |
Is the blood-brain barrier relevant in metastatic germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood-Brain Barrier; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Testicular Neoplasms | 2007 |
Recent developments in germ cell tumors of the testes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Space; Risk Factors; Seminoma; Testicular Neoplasms | 2008 |
High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1995 |
Brain metastasis from clear cell sarcoma of the kidney--a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Frontal Lobe; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Nephrectomy; Vincristine | 1993 |
The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland: a case report and review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Pineal Gland; Syndrome; Teratoma; Vincristine | 1997 |
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chromosome Aberrations; Cisplatin; Diseases in Twins; Etoposide; Female; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Scapula; Shoulder Joint; Time Factors | 2001 |
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Recurrence; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2001 |
Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group.
Topics: Administration, Oral; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasms; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1992 |
The role of etoposide therapy in germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Clinical Trials as Topic; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal | 1992 |
Salvage therapy in recurrent testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1992 |
"Poor-risk" germ cell tumors: current progress and future directions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors; Vinblastine | 1992 |
Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Leukemia, Monocytic, Acute; Neoplasms, Germ Cell and Embryonal; Remission Induction; Sacrococcygeal Region; Time Factors | 1991 |
Salvage therapy in recurrent germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Transplantation, Autologous | 1991 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
Chemotherapy for advanced testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Dysgerminoma; Etoposide; Humans; Incidence; Infertility, Male; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Pulmonary Fibrosis; Raynaud Disease; Risk; Testicular Neoplasms | 1991 |
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Remission Induction | 1990 |
Ifosfamide in testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1990 |
Cancer of the testis: a new paradigm.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Teratoma; Testicular Neoplasms; Vinblastine | 1986 |
Current concepts in clinical therapeutics: testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1987 |
[Chemotherapy of disseminated germ cell tumors of the testis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1987 |
115 trial(s) available for etoposide and Cancer, Embryonal
Article | Year |
---|---|
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat | 2022 |
Neutrophil-to-lymphocyte ratio in primary mediastinal germ cell tumors: A retrospective analysis of >20 years single institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lymphocytes; Male; Mediastinal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Neutrophils; Prognosis; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Young Adult | 2020 |
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II tria
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Vincristine; Young Adult | 2020 |
Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen.
Topics: Adult; Antibiotics, Antineoplastic; Antiemetics; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Incidence; London; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neutropenia; Retrospective Studies; Sepsis; Treatment Outcome | 2021 |
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Monitoring; Etoposide; Female; Genotype; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Pharmacogenetics; Pharmacogenomic Testing; Young Adult | 2020 |
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2021 |
Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection - A 13-year follow-up analysis of a phas
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Young Adult | 2021 |
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2017 |
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Pilot Projects; Survival Rate | 2013 |
Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; DNA; Etoposide; France; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy; Spermatogenesis; Spermatozoa; Testicular Neoplasms; Young Adult | 2013 |
Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2013 |
Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Vincristine; Young Adult | 2014 |
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2014 |
Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Muscle, Skeletal; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Resistance Training; Single-Blind Method; Testicular Neoplasms | 2014 |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Thiotepa; Treatment Failure; Young Adult | 2014 |
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Testicular Neoplasms; Time Factors; Treatment Outcome; United Kingdom; Vincristine; Young Adult | 2015 |
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Combinations; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Young Adult | 2015 |
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Time; Young Adult | 2015 |
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; United States; Young Adult | 2015 |
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Second-Look Surgery; Thiotepa; Treatment Outcome | 2015 |
Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Germany; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prospective Studies; Quality of Life; Surveys and Questionnaires; Testicular Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2016 |
The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Carbon Monoxide; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Radiography, Thoracic; Respiratory Function Tests; Testicular Neoplasms; Vital Capacity; Young Adult | 2016 |
Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Internationality; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prevalence; Risk Factors; Salvage Therapy; Survival Analysis | 2016 |
Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prospective Studies; Risk Factors; Testicular Neoplasms | 2017 |
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Treatment Outcome; Young Adult | 2010 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Retreatment; Salvage Therapy | 2010 |
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2010 |
Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; New Zealand; Prognosis; Quality of Life; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2010 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Stem Cell Transplantation; Testicular Neoplasms; Young Adult | 2011 |
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Norway; Population Surveillance; Prognosis; Sweden; Testicular Neoplasms | 2011 |
Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Young Adult | 2011 |
Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hearing Loss; Humans; Lung Diseases; Male; Neoplasms, Germ Cell and Embryonal; Polyethylene Glycols; Prognosis; Recombinant Proteins | 2011 |
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Treatment Outcome | 2012 |
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Seminoma; Stem Cell Transplantation; Testicular Neoplasms | 2012 |
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Topics: Adult; alpha-Fetoproteins; Biomarkers, Tumor; Carboplatin; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Survival; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2013 |
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Treatment Outcome | 2002 |
The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Infant; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Penile Neoplasms; Survival Rate; Treatment Outcome; Urogenital Neoplasms; Uterine Neoplasms; Vaginal Neoplasms | 2003 |
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prognosis; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Factors; Testicular Neoplasms | 2004 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Stem Cell Transplantation; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2005 |
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Thiotepa; Transplantation, Autologous | 2005 |
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome; Vinblastine | 2005 |
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2005 |
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Ependymoma; Etoposide; Female; Glioma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive, Peripheral; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2005 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prognosis; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2005 |
Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Risk Assessment; Testicular Neoplasms | 2005 |
Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Germinoma; Humans; Infant; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Pilot Projects; Pinealoma; Risk; Treatment Outcome; Vincristine | 2007 |
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2006 |
Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Failure | 2007 |
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Stem Cell Transplantation; Treatment Outcome | 2007 |
Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Time Factors | 2007 |
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Treatment Outcome | 2007 |
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Risk Factors; Survival Analysis; Testicular Neoplasms; Time Factors; Treatment Outcome | 2007 |
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Teratocarcinoma; Testicular Neoplasms | 2007 |
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Germany; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 2007 |
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Treatment Outcome | 2007 |
Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prospective Studies; Risk Factors; Testicular Neoplasms; Time Factors | 2008 |
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Treatment Outcome | 2008 |
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Survival Analysis; Testicular Neoplasms | 2007 |
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors:
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2008 |
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms | 2008 |
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digestive System; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Nervous System; Ovarian Neoplasms; Sarcoma; Survival Rate; Testicular Neoplasms; Transplantation, Autologous | 1995 |
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 1995 |
Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Retrospective Studies; Survival Analysis; Testicular Neoplasms; Vinblastine | 1993 |
High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Risk Factors; Vinblastine | 1993 |
Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retroperitoneal Neoplasms; Survival Analysis; Vincristine | 1993 |
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prospective Studies; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms | 1993 |
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Testicular Neoplasms | 1993 |
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Pancytopenia; Prognosis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 1993 |
D-CECaT: a breakthrough for patients with neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Deferoxamine; Etoposide; Humans; Infant; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Thiotepa | 1993 |
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Transplantation, Autologous | 1995 |
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Resistance; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Failure; Vinblastine | 1994 |
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Seminoma; Survival Analysis; Testicular Neoplasms | 1999 |
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Genital Neoplasms, Female; Genital Neoplasms, Male; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Treatment Outcome | 2000 |
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Taxoids | 2000 |
The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Sacrococcygeal Region; Survival Rate; Treatment Outcome | 2001 |
Malignant mediastinal germ cell tumors: an intergroup study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant, Newborn; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Survival Rate; Treatment Outcome | 2001 |
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tr
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Quality of Life; Seminoma; Testicular Neoplasms; Treatment Outcome | 2001 |
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Recurrence; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome | 2001 |
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous; Treatment Outcome | 1992 |
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mesna; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Testicular Neoplasms; Vinblastine | 1992 |
Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Eruptions; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kidney; Neoplasms, Germ Cell and Embryonal; Skin; Transplantation, Autologous | 1992 |
Extragonadal abdominal germ cell cancers.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retroperitoneal Neoplasms; Survival Analysis; Vinblastine | 1992 |
High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
High dose chemotherapy with carboplatin, VP 16 +/- ifosfamide in germ cell tumors: the Italian experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Italy; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Reoperation | 1991 |
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1991 |
Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Testicular Neoplasms; Vinblastine; Vincristine | 1990 |
The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Remission Induction; Risk Factors; Testicular Neoplasms; Vinblastine | 1990 |
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Remission Induction; Sperm Count; Survival Rate; Testicular Neoplasms | 1991 |
A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Testicular Neoplasms; Vinblastine | 1991 |
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Follow-Up Studies; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Survival Rate; Vinblastine | 1991 |
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Recombinant Proteins; Vinblastine | 1990 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine | 1991 |
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Etoposide; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Survival Rate; United States | 1991 |
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis | 1991 |
Chemotherapy for advanced testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Dysgerminoma; Etoposide; Humans; Incidence; Infertility, Male; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Pulmonary Fibrosis; Raynaud Disease; Risk; Testicular Neoplasms | 1991 |
Two-drug therapy in patients with metastatic germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysgerminoma; Etoposide; Follow-Up Studies; Humans; Male; Neoplasms, Germ Cell and Embryonal; Risk Factors; Testicular Neoplasms | 1991 |
Daily oral etoposide in the treatment of cancer.
Topics: Administration, Oral; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Neoplasms; Neoplasms, Germ Cell and Embryonal | 1991 |
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 1990 |
Cancer of the testis: a new paradigm.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Clinical Trials as Topic; Doxorubicin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Teratoma; Testicular Neoplasms; Vinblastine | 1986 |
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Random Allocation; Vinblastine | 1987 |
Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Random Allocation; Testicular Neoplasms; Vinblastine | 1987 |
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1987 |
Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Evaluation Studies as Topic; Follow-Up Studies; Humans; Male; Nausea; Neoplasms, Germ Cell and Embryonal; Prednisone; Prognosis; Prospective Studies; Teratoma; Testicular Neoplasms; Vinblastine; Vindesine; Vomiting | 1988 |
A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Pulmonary Fibrosis; Random Allocation; Vinblastine | 1988 |
Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Random Allocation; Testicular Neoplasms; Vinblastine | 1988 |
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Random Allocation; Testicular Neoplasms; Vinblastine | 1988 |
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Costs and Cost Analysis; Etoposide; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Random Allocation; Time Factors | 1989 |
Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pulmonary Fibrosis; Retroperitoneal Neoplasms; Testicular Neoplasms | 1985 |
Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies.
Topics: Adult; Blood Proteins; Bone Marrow Transplantation; Cisplatin; Drug Interactions; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal | 1987 |
387 other study(ies) available for etoposide and Cancer, Embryonal
Article | Year |
---|---|
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms | 2022 |
Successful treatment of radiotherapy and apatinib in patient with mediastinal mixed non-seminomatous germ cell tumor: A case report.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Pyridines; Radiotherapy, Intensity-Modulated; Testicular Neoplasms | 2021 |
Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Seminoma; Testicular Neoplasms | 2022 |
Delivering Chemotherapy to a Metastatic Poor Risk Testicular Cancer Patient on Hemodialysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Renal Dialysis; Testicular Neoplasms | 2022 |
[Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tumor Lysis Syndrome | 2022 |
Lymph node metastasis as the initial symptom of a germ cell tumor in an adult: A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2022 |
Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Testicular Neoplasms | 2023 |
[A Case of Remission of Metastatic Germ Cell Tumor in an Elderly Patient by Multimodal Treatment].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2022 |
Outcomes of relapsed/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: Experience from a tertiary cancer center.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms | 2023 |
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Salvage Therapy; Testicular Neoplasms | 2023 |
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Smoking; Testicular Neoplasms | 2023 |
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Conservative Treatment; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Pregnancy; Prognosis; Retrospective Studies; Young Adult | 2023 |
High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Child; Child, Preschool; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2023 |
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis | 2023 |
Mediastinal Presentation of Testicular Embryonal Carcinoma.
Topics: Adult; Carcinoma, Embryonal; Etoposide; Humans; Male; Mediastinum; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2023 |
[A Case of Testicular Cancer with Solitary Iliac Bone Metastasis].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Young Adult | 2023 |
Outcome and late effects of patients treated for childhood vaginal malignant germ cell tumors.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2023 |
Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy; Surveys and Questionnaires; Survivors | 2023 |
Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Carboplatin; Cisplatin; Etoposide; France; Humans; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Population Surveillance; Radiotherapy; Retrospective Studies; Testicular Neoplasms; Time Factors | 2019 |
miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Cohort Studies; Etoposide; Humans; L-Lactate Dehydrogenase; Male; MicroRNAs; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Young Adult | 2019 |
Protective effects of zinc on rat sperm chromatin integrity involvement: DNA methylation, DNA fragmentation, ubiquitination and protamination after bleomycin etoposide and cis-platin treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromatin; Cisplatin; Cytoprotection; DNA Fragmentation; Etoposide; Fertility Preservation; Genomic Instability; Infertility, Male; Male; Neoplasms, Germ Cell and Embryonal; Protamines; Protein Processing, Post-Translational; Rats; Rats, Wistar; Spermatozoa; Testicular Neoplasms; Ubiquitination; Zinc | 2020 |
Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Radiotherapy; Risk Factors; Testicular Neoplasms | 2020 |
Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Oxaliplatin; Paclitaxel; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate | 2020 |
Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2019 |
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Progression-Free Survival; Retrospective Studies; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2020 |
Full-dose cisplatin chemotherapy combined with hemodialysis in a patient with impaired renal function and a mediastinal germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Renal Dialysis; Renal Insufficiency, Chronic; Testicular Neoplasms | 2020 |
Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Lung Diseases; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Young Adult | 2020 |
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Risk Factors; Salvage Therapy | 2020 |
Zero, Some Chemotherapy Game in Early-Stage Germ Cell Tumors.
Topics: Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2020 |
Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Feasibility Studies; Female; Fertility Agents, Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menopause, Premature; Menstruation; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Pregnancy; Primary Ovarian Insufficiency; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
An Abdominal Tumor of Unknown Origin: Acknowledging a Failure to Descend on the Correct Diagnosis.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed | 2020 |
[A Case of Metachronous Testicular Tumor Developing Twenty Years after Treatment of Retroperitoneal Extragonadal Germ Cell Tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms | 2020 |
Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2020 |
Reply to L.H. Einhorn et al.
Topics: Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2020 |
Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Treatment Outcome | 2021 |
[Acute Megakaryoblastic Leukemia Developed after the Surgical Treatment of Mediastinal Malignant Germ Cell Tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 2020 |
Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Transplantation, Autologous | 2021 |
[Mediastinal Growing Teratoma Syndrome during Chemotherapy, Presenting as a Huge and Inoperable Tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Mediastinum; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Young Adult | 2020 |
Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Aortic Rupture; Bleomycin; Cisplatin; Computed Tomography Angiography; Endovascular Procedures; Etoposide; Hemorrhage; Humans; Iliac Vein; Lymph Node Excision; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms; Vascular Neoplasms; Vena Cava, Inferior; Venous Thrombosis | 2020 |
Re: The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
Topics: Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Germ Cells; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2021 |
[A Case of Testicular Tumor with Multiple Metastasis Leading to Complete Response after Treatment Interruption].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Seminoma; Testicular Neoplasms | 2020 |
[A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Induction Chemotherapy; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Young Adult | 2020 |
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; COVID-19; Electronic Nicotine Delivery Systems; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; SARS-CoV-2; Testicular Neoplasms | 2021 |
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting | 2021 |
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Humans; Induction Chemotherapy; Infant; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Retrospective Studies | 2022 |
First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal | 2021 |
Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Disease Models, Animal; Endodermal Sinus Tumor; Etoposide; Female; Heterografts; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2021 |
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Kidney Transplantation; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Renal Insufficiency, Chronic; Risk Assessment; Testicular Neoplasms | 2021 |
Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cohort Studies; Denmark; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paternity; Testicular Neoplasms | 2022 |
Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Osteosarcoma; Palliative Care; Young Adult | 2021 |
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms | 2021 |
Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy | 2021 |
Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Injury; Lung Transplantation; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2017 |
Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Rhabdomyolysis; Testicular Neoplasms; Transplantation, Autologous; Treatment Outcome; Young Adult | 2017 |
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Prognosis; Prospective Studies; Survival Rate | 2017 |
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.
Topics: Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2017 |
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; International Agencies; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Survival Rate; Testicular Neoplasms; Young Adult | 2017 |
Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Induction Chemotherapy; Lymph Node Excision; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2018 |
Improved survival in metastatic germ-cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Progression-Free Survival; Retrospective Studies; Young Adult | 2018 |
Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Young Adult | 2017 |
Re: Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients with Intermediate- or Poor-Risk Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2017 |
Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Platinum; Remission Induction; Testicular Neoplasms; Treatment Outcome | 2018 |
Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung; Lung Diseases; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2018 |
Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Decision Support Techniques; Disease Management; Etoposide; Humans; Lymph Nodes; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Vascular Neoplasms | 2018 |
Symptomatic hyperthyroidism in metastatic testicular mixed germ cell tumour.
Topics: Adult; Bleomycin; Chemoradiotherapy; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Humans; Hyperthyroidism; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2018 |
Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Testicular Neoplasms | 2018 |
Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Length of Stay; Lung; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Operative Time; Postoperative Hemorrhage; Retroperitoneal Space; Testicular Neoplasms; Young Adult | 2018 |
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Clinical Protocols; Clinical Trials, Phase III as Topic; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Research Design; Young Adult | 2018 |
Growing teratoma syndrome in ovarian germ cell tumours - a diagnostic challenge, two case reports.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Disease Progression; Etoposide; Female; Humans; Membrane Proteins; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Syndrome; Teratoma; Young Adult | 2018 |
Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choice Behavior; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Guideline Adherence; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Quality of Life; Standard of Care; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2018 |
Development of angiosarcoma in a mediastinal non-seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy.
Topics: Adult; Biomarkers, Tumor; Bleomycin; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Hemangiosarcoma; Hemorrhage; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Thoracic Surgical Procedures; Tomography, X-Ray Computed | 2019 |
Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ontario; Orchiectomy; Practice Guidelines as Topic; Registries; Retrospective Studies; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2019 |
Solitary Bone Metastasis as the First Presentation of Germ Cell Testicular Cancer Treated with Internal Hemipelvectomy: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Neoplasms; Cisplatin; Etoposide; Hemipelvectomy; Humans; Male; Neoplasm Metastasis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Pelvic Bones; Testicular Neoplasms; Treatment Outcome | 2019 |
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cohort Studies; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Teratoma; Treatment Outcome; Young Adult | 2019 |
Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Monitoring; Etoposide; Feasibility Studies; Follow-Up Studies; Humans; Lung; Lymphocyte Count; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neutrophils; Pneumonia; Predictive Value of Tests; Prognosis; Pulmonary Fibrosis; Respiratory Function Tests; Retrospective Studies; Risk Factors; ROC Curve; Young Adult | 2019 |
Case report: Treatment of metastatic germ cell tumor in a newly diagnosed HIV infected man: use of BEP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; HIV Infections; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2011 |
Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thoracic Surgical Procedures; Time Factors; Treatment Outcome; Young Adult | 2014 |
Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; China; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Infant; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retrospective Studies; Risk Factors; Testicular Neoplasms; Treatment Outcome; Young Adult | 2013 |
[A suspected case of extra-gonadal germ cell tumor complicated with choriocarcinoma syndrome].
Topics: Adult; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Syndrome | 2013 |
Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Topics: Adult; Antineoplastic Agents; Bleomycin; Cisplatin; Creatinine; Etoposide; Glomerular Filtration Rate; Humans; Kidney; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms; Young Adult | 2013 |
Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Myeloid Cells; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Salvage Therapy; Treatment Outcome | 2013 |
Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous; Young Adult | 2013 |
Regeneration of spermatogenesis after testicular cancer chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Cisplatin; Cryopreservation; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Semen; Spermatogenesis; Testicular Neoplasms; Young Adult | 2013 |
Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Treatment Outcome | 2014 |
Assessing therapy response of secreting pineal germ cell tumor on simultaneous 18F-choline PET/MRI.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choline; Cisplatin; Cyclophosphamide; Etoposide; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2014 |
[A case of a nonseminomatous germ cell tumor responding to MEA therapy].
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2013 |
Metastatic germ cell tumour following renal transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Spinal Dysraphism; Treatment Outcome | 2013 |
Flagellate erythema.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Eruptions; Erythema; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Young Adult | 2013 |
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Radiography; Risk Factors; Salvage Therapy; Time Factors; Treatment Outcome | 2014 |
[Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Eruptions; Drug Substitution; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prednisolone; Testicular Neoplasms | 2014 |
Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Bleomycin; Carboplatin; Cisplatin; Creatinine; Etoposide; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Reproducibility of Results | 2014 |
Treatment outcomes of female germ cell tumors: the Egyptian National Cancer Institute experience.
Topics: Adolescent; Adult; Aged; Cisplatin; Disease-Free Survival; Etoposide; Female; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Treatment Outcome | 2014 |
Pitfalls in management of patients with germ cell tumors and slight elevation of serum α-fetoprotein.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Platinum Compounds | 2014 |
[Modified BEP regimen leads to abatement of choriocarcinoma syndrome in a patient with extra gonadal germ cell tumor : a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma, Non-gestational; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Respiratory Distress Syndrome; Syndrome | 2014 |
[A case of lung abscess during chemotherapy for testicular tumor].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Abscess; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2014 |
The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Treatment Outcome | 2014 |
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Topics: Adult; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Retrospective Studies; Survival Rate; Testicular Neoplasms | 2013 |
Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms; Vincristine | 2017 |
Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Induction Chemotherapy; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Risk Assessment; Teratoma; Testicular Neoplasms | 2015 |
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Chemotherapy, Adjuvant; Etoposide; Humans; Incidence; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Norway; Orchiectomy; Prospective Studies; Risk Factors; Sweden; Testicular Neoplasms; Testis; Time Factors; Vinblastine; Watchful Waiting | 2015 |
The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Retrospective Studies; Risk Assessment; Testicular Neoplasms; Young Adult | 2015 |
Renal impairment and late toxicity in germ-cell cancer survivors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Cisplatin; Etoposide; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Renal Insufficiency; Young Adult | 2015 |
Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Risk Assessment; Testicular Neoplasms | 2015 |
Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Adjustment; Testicular Neoplasms; Vinblastine; Young Adult | 2014 |
Laparoendoscopic single-site retroperitoneal lymph node dissection in non-seminomatous germ cell malignancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Testicular Neoplasms; Umbilicus | 2015 |
Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Metastasectomy; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Recurrence; Remission Induction; Testicular Neoplasms; Treatment Outcome; Young Adult | 2014 |
High-dose chemotherapy for recurrent ovarian germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome; Vinblastine | 2015 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organ Sparing Treatments; Ovarian Neoplasms; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Laparotomy; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Salpingostomy; Teratoma; Treatment Outcome; Young Adult | 2014 |
High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Saudi Arabia; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vincristine | 2015 |
Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Dacarbazine; Disease-Free Survival; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Treatment Results of Extracranial Malignant Germ Cell Tumor with Regimens of Cisplatin, Vinblastine, Bleomycin or Carboplatin, Etoposide, and Bleomycin with Special Emphasis on the Sites of Vagina and Testis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Treatment Outcome; Vaginal Neoplasms; Vinblastine | 2015 |
Mediastinal germ cell tumour causing superior vena cava tumour thrombosis.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chest Pain; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Heparin, Low-Molecular-Weight; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Treatment Outcome; Vena Cava, Superior; Venous Thromboembolism | 2015 |
[Germ cell tumors].
Topics: Antineoplastic Agents; Bleomycin; Cisplatin; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors | 2015 |
Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Treatment Outcome | 2015 |
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Camptothecin; Cisplatin; Etoposide; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retreatment; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult | 2016 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Young Adult | 2015 |
Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Longitudinal Studies; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 2015 |
Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report.
Topics: Adult; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Etoposide; Foramen Ovale, Patent; Humans; Hypoxia; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oxygen Inhalation Therapy | 2015 |
Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cisplatin; Databases, Factual; Denmark; Disease Progression; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Proportional Hazards Models; Radiotherapy Dosage; Retreatment; Risk Factors; Testicular Neoplasms; Time Factors; Treatment Failure | 2015 |
Activity of nintedanib in germ cell tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Bleomycin; Cell Cycle; Cell Line, Tumor; Cell Survival; Chick Embryo; Chorioallantoic Membrane; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Etoposide; Humans; Indoles; Male; Neoplasms, Germ Cell and Embryonal | 2016 |
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Decision Making; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2016 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Retroperitoneal Neoplasms; Risk Assessment; Survival Rate; Testicular Neoplasms; Vaginal Neoplasms; Vinblastine | 2016 |
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2016 |
Bleomycin induced flagellate erythema in a patient with thalamic mixed germ cell tumour: Report of a rare adverse effect.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bleomycin; Cetirizine; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Combined Modality Therapy; Craniospinal Irradiation; Erythema; Etoposide; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Supratentorial Neoplasms; Thalamus | 2016 |
[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].
Topics: Adult; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2016 |
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Male; Multicenter Studies as Topic; Neoplasms, Germ Cell and Embryonal; New Zealand; Prostatic Neoplasms; Time Factors; Treatment Outcome; Urogenital Neoplasms | 2016 |
Clinical and Radiologic Features of Pediatric Basal Ganglia Germ Cell Tumors.
Topics: Adolescent; Aftercare; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia Diseases; Brain Neoplasms; Carboplatin; Carcinoma, Embryonal; Caudate Nucleus; Child; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Cognitive Dysfunction; Corpus Striatum; Cranial Irradiation; Diffusion Tensor Imaging; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Neurosurgical Procedures; Paresis; Retrospective Studies; Second-Look Surgery; Seizures; Tomography, X-Ray Computed | 2016 |
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2017 |
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Humans; Ifosfamide; Indiana; Lung Neoplasms; Male; Mediastinal Neoplasms; Metastasectomy; Middle Aged; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Pneumonectomy; Postoperative Complications; Retrospective Studies; Risk Factors; Testicular Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2016 |
A Case of Mixed Germ Cell Tumor in the Intramedullary Spinal-cord.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Guillain-Barre Syndrome; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Paraplegia; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2016 |
Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2017 |
Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Denmark; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2016 |
Intestinal Lipomatosis and Chemotherapy: A Growing Concern.
Topics: Adult; Anemia, Iron-Deficiency; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Colonoscopy; Etoposide; Humans; Intestinal Neoplasms; Lipoma; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Orchiectomy; Testicular Neoplasms | 2016 |
Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Carboplatin; Cyclams; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Thiotepa | 2017 |
[Severe Acute Myocardial Infarction during Induction Chemotherapy for Retroperitoneal Germ Cell Tumor : A Case Report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Induction Chemotherapy; Male; Myocardial Infarction; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Testicular Neoplasms | 2016 |
Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemoradiotherapy, Adjuvant; Child; Cisplatin; Etoposide; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Registries; Seminoma; Survival Rate; Testicular Neoplasms; Testis; Treatment Outcome; Young Adult | 2017 |
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Proportional Hazards Models; Registries; Survival Rate; Venous Thromboembolism; Young Adult | 2017 |
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Bleomycin; Case-Control Studies; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Hearing Loss; Humans; Longitudinal Studies; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Platinum; Vinblastine; Young Adult | 2017 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cisplatin; Compassionate Use Trials; Endodermal Sinus Tumor; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Nivolumab; Platinum Compounds; Programmed Cell Death 1 Receptor; Retrospective Studies; Seminoma; Stem Cell Transplantation; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome | 2017 |
[Clinical Study to Determine the Dose Intensity of BEP Chemotherapy for Ovarian Malignant Germ Cell Tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Treatment Outcome | 2017 |
Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Assessment; Survival Analysis; Vincristine | 2008 |
Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cluster Analysis; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Germ Cells; Male; Neoplasms, Germ Cell and Embryonal; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred BN; Spermatids; Spermatogenesis; Testicular Neoplasms; Urogenital System | 2009 |
High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal | 2009 |
Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cryptorchidism; Down Syndrome; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mexico; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Retroperitoneal Neoplasms; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2008 |
[Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Loss, Surgical; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Disease-Free Survival; Etoposide; Follow-Up Studies; Germinoma; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Space; Retrospective Studies; Testicular Neoplasms; Young Adult | 2008 |
Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Nerve Tissue Proteins; Orchiectomy; Paraneoplastic Syndromes, Nervous System; Testicular Neoplasms | 2008 |
Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms, Germ Cell and Embryonal; Survival Rate | 2009 |
Vox populi: Using community-based studies to determine best management of early-stage nonseminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2009 |
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 2009 |
Cerebrovascular accident after chemotherapy for testicular cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Stroke; Testicular Neoplasms | 2009 |
High-risk clinical stage I NSGCT: the case for RPLND.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Risk Factors; Testicular Neoplasms | 2009 |
Cisplatin-based chemotherapy followed by surgery for malignant nonseminomatous germ cell tumor of mediastinum: one institution's experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis | 2009 |
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Failure; Treatment Outcome; Young Adult | 2010 |
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retrospective Studies; Testicular Neoplasms; Young Adult | 2009 |
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Germinoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Young Adult | 2010 |
Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Combined Modality Therapy; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Sarcoma; Young Adult | 2010 |
[Result of treatment for advanced germ cell tumor in the last decade].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Young Adult | 2010 |
[Case of far-advanced retroperitoneal extra-gonadal germ cell tumor responding to intensive treatment including multi-drug chemotherapy with peripheral blood stem cell transplantation and residual tumor removal].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retroperitoneal Neoplasms; Treatment Outcome | 2010 |
Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Research Design; Testicular Neoplasms; Treatment Outcome | 2010 |
Evidence-based treatment for advanced germ cell tumor of the testis with a case illustration.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Evidence-Based Practice; Follow-Up Studies; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed | 2010 |
Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Choroid Neoplasms; Dactinomycin; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2010 |
Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Salvage Therapy; Testicular Neoplasms | 2010 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Ependymoma; Etoposide; Female; Glioblastoma; Hematologic Diseases; Humans; Ifosfamide; Infant; Male; Medulloblastoma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Retrospective Studies | 2010 |
Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor.
Topics: Antineoplastic Agents; Benzylamines; Carboplatin; Cyclams; Etoposide; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous | 2010 |
[Case of a testicular germ cell tumor presenting with multiple metastasized pulmonary nodules and masses].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Gynecomastia; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Tomography, X-Ray Computed | 2010 |
New onset psychosis in an adolescent during treatment of testicular germ cell tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Injuries; Cisplatin; Dexamethasone; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Psychotic Disorders; Testicular Neoplasms | 2011 |
[A case of germ-cell tumor of the mediastinum].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 2011 |
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Databases, Factual; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Thiotepa; Vinblastine; Young Adult | 2011 |
Bleomycin-induced flagellate dermatitis.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Bleomycin; Cisplatin; Drug Eruptions; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prednisone; Testicular Neoplasms | 2011 |
Therapy-associated secondary tumors in patients with non-germinomatous malignant germ cell tumors.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Hemangioma, Cavernous; Humans; Maintenance Chemotherapy; Male; Meningeal Neoplasms; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Prognosis; Survival Rate; Young Adult | 2011 |
Giant mediastinal germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Taxoids; Testicular Neoplasms; Wilms Tumor; Young Adult | 2011 |
Intracranial germ cell tumors: efficacy of neoadjuvant chemo-radiotherapy without surgical biopsy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carboplatin; Child; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Neoplasms, Germ Cell and Embryonal; Proportional Hazards Models; Radiotherapy Dosage; Treatment Outcome; Young Adult | 2011 |
Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Time Factors; Young Adult | 2013 |
Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Isochromosomes; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Republic of Korea; Shock, Septic | 2011 |
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2012 |
Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Space; Retrospective Studies; Teratoma; Testicular Neoplasms; Young Adult | 2012 |
Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Body Height; Brain Neoplasms; Carboplatin; Chemoradiotherapy; Child; Cranial Irradiation; Craniospinal Irradiation; Disease-Free Survival; Endocrine Glands; Etoposide; Female; Growth; Growth Hormone; Humans; Male; Neoplasms, Germ Cell and Embryonal; Obesity; Pituitary Hormones; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Survival Rate; Treatment Outcome; Trophoblasts; Young Adult | 2012 |
Germ cell tumor metastatic to the oral cavity.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mouth; Mouth Neoplasms; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms | 2012 |
Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Follow-Up Studies; Half-Life; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Testicular Neoplasms; Young Adult | 2012 |
Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2013 |
Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Malaysia; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2012 |
Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiotherapy, Adjuvant; Risk Factors; Seminoma; Testicular Neoplasms | 2012 |
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiovascular Diseases; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Quality of Life; Stem Cell Transplantation; Surveys and Questionnaires; Survivors; Treatment Outcome; Young Adult | 2013 |
Systemic thromboembolism after anti-cancer chemotherapy in a woman with ovarian germ cell tumor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Infarction; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Thromboembolism | 2013 |
[Neutropenia and fever of unknown origin].
Topics: Algorithms; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Fever of Unknown Origin; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prognosis; Testicular Neoplasms; Young Adult | 2012 |
Prediction of cytotoxic drug concentrations occurring on the day of autologous stem cell rescue during a high-dose chemotherapy regimen.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromatography, High Pressure Liquid; Cytotoxins; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasms, Germ Cell and Embryonal; Spectrophotometry, Atomic; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Thiotepa; Thrombocytopenia | 2013 |
Unusual intrathoracic location of a primary germ cell tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Choriocarcinoma; Cisplatin; Endodermal Sinus Tumor; Etoposide; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Tomography, X-Ray Computed | 2002 |
Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cannabis; Carboplatin; Drug Interactions; Etoposide; Fatal Outcome; Humans; Male; Neoplasms, Germ Cell and Embryonal; Stroke; Testicular Neoplasms | 2002 |
Gynecomastia following chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Gynecomastia; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2003 |
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Peritoneal Neoplasms; Teratoma; Testicular Neoplasms | 2003 |
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Peritoneum; Statistics, Nonparametric; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Prostate carcinoma presenting as multiple pulmonary nodules in an asymptomatic patient with a history of testicular nonseminomatous germ cell tumor.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Flutamide; Humans; Leuprolide; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Orchiectomy; Postoperative Complications; Prostatic Neoplasms; Radiography; Testicular Neoplasms | 2003 |
[Metachronous testicular tumor of an extragonadal germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Etoposide; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Reoperation; Retroperitoneal Neoplasms; Testicular Neoplasms; Testis | 2003 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Paclitaxel | 2004 |
[Mediastinal non seminomatous germ cell tumor successfully treated with chemotherapy and curative surgery; report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasm Invasiveness; Neoplasms, Germ Cell and Embryonal; Pneumonectomy; Salvage Therapy; Sternum; Thoracotomy; Treatment Outcome | 2004 |
[Testicular cancer with inferior vena caval embolus causing pulmonary embolism following chemotherapy: a case report].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Embolism; Etoposide; Humans; Leukemia, Myeloid; Male; Neoplasms, Germ Cell and Embryonal; Pulmonary Embolism; Testicular Neoplasms; Vena Cava Filters; Vena Cava, Inferior | 2004 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Necrosis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retroperitoneal Neoplasms; Retrospective Studies; Testicular Neoplasms | 2004 |
[Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diterpenes; Drug Administration Schedule; Etoposide; Germinoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Observer Variation; Retroperitoneal Neoplasms; Seminoma; Testicular Neoplasms | 2005 |
Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Child; Cisplatin; Combined Modality Therapy; Cross-Linking Reagents; Etoposide; Humans; Hyperthermia, Induced; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Topoisomerase II Inhibitors | 2005 |
Images in neuro-oncology: brain metastases and leptomeningeal dissemination of nonseminomatous germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Embryonal Carcinoma Stem Cells; Etoposide; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplastic Stem Cells; Testicular Neoplasms; Tomography, X-Ray Computed | 2005 |
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Hearing Disorders; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Pilot Projects; Radiation-Protective Agents | 2005 |
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Salvage Therapy; Treatment Outcome | 2006 |
[International study on testicular cancer: EORTC 30983: randomized phase II/III study of Taxol-BEP versus BEP in patients with Intermediate Prognosis Germ Cell Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Etoposide; Humans; Internationality; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Randomized Controlled Trials as Topic; Testicular Neoplasms; Treatment Outcome | 2005 |
One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumor of the testis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Disease Progression; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
[A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Testicular Neoplasms | 2005 |
Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
Topics: Adult; Bleomycin; Cisplatin; DNA Damage; Drug Therapy, Combination; Etoposide; Follicle Stimulating Hormone; Humans; In Situ Nick-End Labeling; Luteinizing Hormone; Male; Neoplasms, Germ Cell and Embryonal; Semen; Sperm Count; Spermatogenesis; Spermatozoa; Testicular Neoplasms; Testosterone | 2006 |
Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; False Negative Reactions; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Predictive Value of Tests; Sensitivity and Specificity; Testicular Neoplasms; Testis; Time Factors | 2006 |
[Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Retroperitoneal Neoplasms; Salvage Therapy; Taxoids; Testicular Neoplasms | 2006 |
Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Risk Assessment; Risk Factors | 2006 |
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Outcome | 2006 |
Usefulness of positron emission tomography (PET) in a retroperitoneal primary non-seminomatous germ cell tumor: a case report.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Retroperitoneal Neoplasms | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Retroperitoneal Neoplasms | 2006 |
Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms | 2006 |
Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2006 |
Three cycles of etoposide and cisplatin chemotherapy in clinical stage IS nonseminomatous testicular cancer.
Topics: Adult; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2006 |
[Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Survival Rate; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine | 2006 |
Acute respiratory distress in a bleomycin primed patient: a new use for nitric oxide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Nitric Oxide; Respiratory Distress Syndrome; Retroperitoneal Neoplasms; Testicular Neoplasms | 2007 |
[Chemotherapy for metastatic germ cell tumours of the testis].
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Factors; Seminoma; Testicular Neoplasms; Time Factors; Treatment Outcome | 2007 |
Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Multivariate Analysis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Retrospective Studies; Salvage Therapy; Vinblastine | 2007 |
[Multiple hepatic metastases due to germ cell tumor on initial clinical presentation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Drug Administration Routes; Etoposide; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 2007 |
Pulmonary alterations during BEP? Always be aware of BIP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Pneumonia; Positron-Emission Tomography; Prognosis; Respiratory Function Tests; Testicular Neoplasms | 2007 |
Malignant transformation of a well-organized sacrococcygeal fetiform teratoma in a newborn male.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fetus; Humans; Infant, Newborn; Male; Neoplasms, Germ Cell and Embryonal; Pregnancy; Reoperation; Sacrococcygeal Region; Teratoma; Treatment Outcome | 2007 |
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms | 2007 |
[Inductive systemic therapy of urological tumors with curative intent].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Delivery Systems; Etoposide; Humans; Ifosfamide; Lymph Node Excision; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Seminoma; Survival Rate; Taxoids; Testicular Neoplasms; Treatment Outcome; Vinblastine | 2007 |
[Testicular cancer--is there an indication for adjuvant or neoadjuvant systemic therapy?].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Lymph Node Excision; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Testicular Neoplasms | 2007 |
Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: interpretation of the current body of knowledge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Prognosis; Quality of Life | 2007 |
The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Retrospective Studies; Salvage Therapy; Secondary Prevention; Testicular Neoplasms; Treatment Outcome | 2007 |
Germ-cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms | 2007 |
A child with primary germ cell tumor of the liver.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Etoposide; Humans; Liver Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Vinblastine | 2007 |
[Clinical analysis of primary mediastinal germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retrospective Studies; Seminoma; Survival Rate; Taxoids; Young Adult | 2007 |
Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Salvage Therapy; Testicular Neoplasms; Time Factors; Treatment Outcome | 2008 |
Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 2007 |
Celiac trunk thrombosis and splenic infarction during chemotherapy for a testicular germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Artery; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Splenic Infarction; Testicular Neoplasms; Thrombosis; Tomography, X-Ray Computed | 2008 |
Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Genotype; Humans; Male; Neoplasms, Germ Cell and Embryonal; Pharmacogenetics; Polymorphism, Genetic; Prognosis; Pulmonary Fibrosis; Testicular Neoplasms | 2008 |
Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Cysteine Endopeptidases; Etoposide; Genetic Variation; Genotype; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prognosis; Pulmonary Fibrosis; Regression Analysis; Survival Rate; Testicular Neoplasms | 2008 |
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Premedication; Retrospective Studies; Transplantation, Autologous | 2008 |
[Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Survival Rate | 2008 |
Stage I testicular cancer management and necessity for surgical expertise.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 2008 |
Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Transplantation, Autologous | 1984 |
Pulmonary blastoma: remission with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Pneumonectomy; Vincristine | 1984 |
Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin | 1984 |
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dysgerminoma; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms | 1983 |
Chemotherapy of primary (in situ) testicular tumours: response in advanced metastatic disease.
Topics: Abdomen; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1983 |
Recurrent testis cancer: seeding from retroperitoneal nodes after complete remissions by chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Seeding; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Testicular Neoplasms; Vinblastine | 1983 |
Twenty years of anaplastic germ cell tumours.
Topics: Adult; alpha-Fetoproteins; Child; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy; Prognosis; Testicular Neoplasms; Uterine Neoplasms | 1984 |
VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Topics: Adolescent; Adult; Cisplatin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms | 1982 |
Etoposide salvage therapy for refractory germ cell tumors: an update.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms | 1982 |
Etoposide-induced hepatic injury: a potential complication of high-dose therapy.
Topics: Adult; Chemical and Drug Induced Liver Injury; Etoposide; Humans; Liver Diseases; Liver Function Tests; Male; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin | 1983 |
Chemotherapy of refractory germ cell cancer with Etoposide.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Choriocarcinoma; Cisplatin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Male; Mesonephroma; Nausea; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Retroperitoneal Neoplasms; Testicular Neoplasms | 1983 |
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal | 1984 |
Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Testicular Neoplasms; Transplantation, Autologous; Vinblastine | 1994 |
Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Recurrence; Retroperitoneal Space; Risk Factors; Testicular Neoplasms | 1994 |
Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Vinblastine | 1995 |
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorpromazine; Cisplatin; Drug Interactions; Etoposide; Humans; Hydroxyindoleacetic Acid; Indoles; Infusions, Intravenous; Neoplasms, Germ Cell and Embryonal; Serotonin; Serotonin Antagonists; Tropisetron; Vomiting | 1995 |
Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Translocation, Genetic | 1993 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
Bleomycin lung toxicity detected by technetium-99m diethylene triamine penta-acetic acid aerosol scintigraphy.
Topics: Adult; Aerosols; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung; Male; Neoplasms, Germ Cell and Embryonal; Pulmonary Fibrosis; Radionuclide Imaging; Respiratory Function Tests; Technetium Tc 99m Pentetate; Time Factors | 1993 |
Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16).
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Teratoma | 1993 |
Malignant germ cell tumours in two siblings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Choriocarcinoma; Dysgerminoma; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Nuclear Family; Ovarian Neoplasms | 1993 |
[Benign enlargement of the thymus after chemotherapy of metastasizing testicular cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Thymus Hyperplasia; Tomography, X-Ray Computed | 1993 |
[New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Salvage Therapy; Testicular Neoplasms | 1993 |
[Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms; Testis | 1993 |
Current chemotherapy strategy in patients with germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1993 |
Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Risk Factors; Testicular Neoplasms | 1993 |
Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retrospective Studies; Treatment Outcome | 1993 |
Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Transplantation, Autologous | 1993 |
Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line.
Topics: Animals; Antigens, Differentiation; Cell Cycle; Cell Differentiation; Cell Survival; Cisplatin; DNA, Neoplasm; Drug Synergism; Etoposide; Mice; Neoplasms, Germ Cell and Embryonal; Tretinoin; Tumor Cells, Cultured | 1993 |
Intratesticular effects of cisplatin-based chemotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Etoposide; Germ Cells; Humans; Ifosfamide; Immunohistochemistry; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Sertoli Cells; Testicular Neoplasms | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pregnancy; Prognosis; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
[Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prospective Studies; Testicular Neoplasms | 1995 |
Clinical efficacy of perceived 'CNS friendly' chemoradiotherapy for primary intracranial germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Combined Modality Therapy; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Vincristine | 1997 |
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Endodermal Sinus Tumor; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Seminoma; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.
Topics: Cell Transformation, Neoplastic; Chromosomes, Human, Pair 11; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription, Genetic; Translocation, Genetic | 1999 |
[Colony stimulating factors in polychemotherapy of testicular tumors. A comparison between G-CSF and GM-CSF].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Leukopenia; Male; Neoplasms, Germ Cell and Embryonal; Recombinant Proteins; Testicular Neoplasms; Treatment Outcome | 1999 |
High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Risk Factors; Survival Analysis; Treatment Outcome | 2000 |
Pancreatoblastoma treated by delayed operation after effective chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Neoplasms, Germ Cell and Embryonal; Pancreatectomy; Pancreatic Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Therapeutic Equivalency | 2001 |
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Practice Guidelines as Topic; Radiotherapy; Risk Assessment; Testicular Neoplasms; Treatment Outcome | 2001 |
Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasms, Germ Cell and Embryonal; Risk Factors; Transplantation, Isogeneic; Treatment Outcome | 2002 |
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Topics: Abdomen; Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Diagnosis, Differential; Etoposide; Humans; Immunohistochemistry; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Pancreatic Neoplasms; Pancreaticoduodenectomy; Status Epilepticus | 2002 |
Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms | 1992 |
Intracranial germ cell tumours: I. Experience with platinum based chemotherapy and implications for curative chemoradiotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Vincristine | 1992 |
[BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Dysgerminoma; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1992 |
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Remission Induction; Time Factors | 1992 |
Penetration of etoposide into human malignant brain tumors after intravenous and oral administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Brain Neoplasms; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Etoposide; Female; Glioma; Humans; Injections, Intravenous; Lymphoma; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Time Factors | 1992 |
Intracranial germ cell tumours: II. The application of a partial transmission block technique to reduce late morbidity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Pinealoma; Radiotherapy Dosage; Vincristine | 1992 |
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine | 1992 |
Brain metastases and testicular tumors: long-term survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Mesonephroma; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Retrospective Studies; Teratoma; Testicular Neoplasms | 1992 |
Further practical experiences in the recognition and management of carcinoma in situ of the testis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Incidence; Male; Neoplasms, Germ Cell and Embryonal; Radiotherapy Dosage; Testicular Neoplasms; Testis | 1992 |
Treatment of metastatic testicular tumours with bleomycin, etoposide, cisplatin and vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vincristine | 1992 |
Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Reproduction; Retrospective Studies; Uterus; Vinblastine; Vincristine | 1992 |
Ovarian germ cell malignancies: the Yale University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Vinblastine; Vincristine | 1992 |
Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal | 1992 |
Treatment of poor-risk germ-cell tumors with high-dose cisplatin and etoposide combined with bleomycin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Factors | 1992 |
The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Teratoma; Testicular Neoplasms | 1992 |
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Clinical Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Unknown Primary; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine | 1992 |
[Recent advances in ovarian cancer chemotherapy].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Infusions, Parenteral; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Taxoids | 1992 |
High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clostridioides difficile; Diarrhea; Etoposide; Humans; Immunocompromised Host; Neoplasms, Germ Cell and Embryonal; Prevalence; Prospective Studies | 1992 |
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Recurrence; Survival Rate; Testicular Neoplasms | 1991 |
Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Transplantation, Autologous | 1991 |
Secondary pre-leukaemia and etoposide.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Neural Tube Defects | 1991 |
Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Risk Factors; Testicular Neoplasms | 1990 |
[A case of complete remission obtained with etoposide cis-platinum combination chemotherapy in advanced testicular cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Testicular Neoplasms; Vinblastine | 1990 |
Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prospective Studies | 1990 |
The UK Children's Cancer Study Group: testicular malignant germ cell tumours 1979-1988.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Clinical Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Peptichemio; Prednisone; Testicular Neoplasms; United Kingdom; Vincristine | 1990 |
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Risk Factors; Survival Rate | 1990 |
Management of patients with poor-prognosis nonseminomatous germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Rate; Vindesine | 1990 |
Postoperative chemotherapy for primary intracranial germ cell tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Postoperative Period; Vincristine | 1990 |
The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Time Factors | 1990 |
'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Lung; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds | 1990 |
Poor prognosis of mediastinal germ cell cancers containing sarcomatous components.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Etoposide; Humans; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Prognosis; Sarcoma; Survival Rate; Vincristine | 1990 |
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Brain Neoplasms; Cerebrospinal Fluid Shunts; Child; Chorionic Gonadotropin; Cisplatin; Cranial Irradiation; Etoposide; Female; Humans; Hydrocephalus; Male; Neoplasm Proteins; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Remission Induction; Vinblastine; Zinostatin | 1990 |
Treatment of malignant germ cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Survival Rate; Testicular Neoplasms | 1990 |
Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy.
Topics: Adult; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Creatine Kinase; Echocardiography; Electrocardiography; Etoposide; Humans; Isoenzymes; Male; Myocardial Infarction; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Tomography, Emission-Computed, Single-Photon | 1991 |
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cisplatin; Cohort Studies; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Risk Factors | 1991 |
[Tumor markers--personal experience. A case of advanced extragonadal germ-cell tumor showing complete remission by high-dose combination chemotherapy with autologous bone marrow transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal | 1991 |
[BEP (bleomycin, etoposide, cisplatinum) chemotherapy as an induction therapy of advanced extragonadal germ cell tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retroperitoneal Neoplasms | 1991 |
Non-seminomatous germ cell tumours of the testis: game and set but not match.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms | 1991 |
Role of chemotherapy in pediatric pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Thoracic Neoplasms; Vincristine | 1990 |
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Evaluation; Etoposide; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Stomatitis; Testicular Neoplasms; Time Factors | 1990 |
Cutaneous toxicity of autologous bone marrow transplantation in nonseminomatous germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dermatitis; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Autologous | 1990 |
Phase II study of daily oral etoposide in refractory germ cell tumors.
Topics: Administration, Oral; Adult; Drug Administration Schedule; Drug Evaluation; Etoposide; Hematologic Diseases; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Germ Cell and Embryonal; Remission Induction; Retroperitoneal Neoplasms; Survival Rate; Testicular Neoplasms | 1990 |
Chronic daily administration of oral etoposide.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms; Neoplasms, Germ Cell and Embryonal | 1990 |
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Testicular Neoplasms | 1990 |
Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Kidney; Kidney Transplantation; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1990 |
[High dose chemotherapy and autologous bone marrow transplantation for advanced germ cell tumor].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Nimustine; Testicular Neoplasms | 1990 |
[Platinum-based combination chemotherapy for malignant mixed mesodermal tumor of the ovary: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction | 1990 |
Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1985 |
Successful treatment of mediastinal germ cell/endodermal sinus tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Mediastinal Neoplasms; Mesonephroma; Neoplasms, Germ Cell and Embryonal; Radiography, Thoracic | 1985 |
Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Dysgerminoma; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Time Factors; Vinblastine; Vomiting | 1985 |
Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; Male; Mesonephroma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms | 1985 |
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1985 |
High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Coccyx; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Reoperation; Testicular Neoplasms; Vinblastine | 1986 |
VP-16-213 (etoposide) in the management of germinal testis tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms; Vinblastine | 1985 |
The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1985 |
Successful management of metastatic and primary germ cell tumors in the brain.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Tomography, X-Ray Computed; Vincristine | 1986 |
[Advanced non-seminoma germinal tumors of the testicle. Therapeutic strategy and method of action of chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1986 |
Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Risk; Teratoma; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 1986 |
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Bleomycin; Cerebrovascular Disorders; Cisplatin; Dysgerminoma; Etoposide; Humans; Ischemia; Male; Myocardial Infarction; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vinblastine | 1986 |
Current optimum management of anaplastic germ cell tumours of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vincristine | 1986 |
High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1986 |
High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iodohippuric Acid; Kidney; Leukopenia; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1986 |
Possible benefit of doxorubicin treatment in patients with refractory germ cell cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Testicular Neoplasms | 1986 |
Treatment of persistent or relapsing advanced germ cell neoplasms with cisplatin, etoposide and bleomycin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Vinblastine | 1986 |
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Risk; Testicular Neoplasms; Vinblastine | 1987 |
Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Vinblastine | 1986 |
Fertility after chemotherapy for ovarian germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Vincristine | 1987 |
Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms | 1987 |
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Kidney; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Renin; Testicular Neoplasms; Vinblastine | 1987 |
Pituitary and testicular hormonal function after treatment for germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Neoplasms, Germ Cell and Embryonal; Pituitary Gland; Testicular Neoplasms; Testis; Testosterone; Vinblastine | 1987 |
Fertility after chemotherapy for male and female germ cell tumours.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menstruation; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Spermatogenesis; Testicular Neoplasms; Vincristine | 1987 |
Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms | 1987 |
Reassessment of the role of adjunctive surgical therapy in the treatment of advanced germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Humans; Lung Neoplasms; Lymph Node Excision; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms; Vinblastine; Vincristine | 1987 |
[VP-16 salvage therapy of PVB regimen-resistant testicular germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Resistance; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1987 |
A multidisciplinary approach to primary nonseminomatous germ cell tumors of the mediastinum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Mediastinum; Neoplasms, Germ Cell and Embryonal; Pneumonectomy; Preoperative Care; Prognosis; Thymectomy; Vinblastine | 1987 |
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Neoplasms; Vinblastine; Vincristine | 1988 |
Management of high risk patients with advanced testis cancer: National Cancer Institute approach.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Pilot Projects; Prospective Studies; Random Allocation; Testicular Neoplasms; Vinblastine | 1988 |
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1988 |
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Vincristine | 1989 |
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Neoplasms, Germ Cell and Embryonal; Vincristine | 1989 |
Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Genital Neoplasms, Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Sacrococcygeal Region; Testicular Neoplasms; Vinblastine; Vincristine | 1989 |
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1989 |
Treatment of disseminated germ cell tumours of the testis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine | 1989 |
Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
Topics: Animals; Antineoplastic Agents; Bleomycin; Carboplatin; Cisplatin; Etoposide; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Testicular Neoplasms; Transplantation, Heterologous; Vinblastine | 1989 |
Effects of antineoplastic treatment of HIV-positive patients with testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; HIV Seropositivity; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1989 |
Ambulatory infusion of bleomycin in patients receiving chemotherapy for germ cell tumors.
Topics: Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Male; Neoplasms, Germ Cell and Embryonal | 1989 |
[A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide].
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Sella Turcica; Vinblastine | 1989 |
Ifosfamide in testicular cancer: the Indiana University experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1989 |
Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; DNA; Drug Screening Assays, Antitumor; Etoposide; Female; Flow Cytometry; Humans; Male; Neoplasms, Germ Cell and Embryonal; Tomography, X-Ray Computed; Tumor Cells, Cultured | 1989 |
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms | 1989 |
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Humans; Ifosfamide; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms | 1989 |
Third-line chemotherapy of resistant advanced testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Dysgerminoma; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Teratoma; Testicular Neoplasms | 1989 |
VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Pregnancy; Uterine Neoplasms; Vincristine | 1985 |
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Etoposide; Humans; Leukopenia; Male; Mouth Mucosa; Neoplasms, Germ Cell and Embryonal; Stomatitis; Testicular Neoplasms; Thrombocytopenia | 1988 |
Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Kidney Diseases; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Prognosis; Prospective Studies; Remission Induction; Vinblastine | 1988 |
Extragenital malignant mixed Müllerian tumor: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Peritoneal Neoplasms | 1988 |
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Fever; Follow-Up Studies; Humans; Male; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Prognosis; Teratoma | 1985 |
Etoposide and very high dose cisplatin: salvage therapy for patients with advanced germ cell neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Hearing Disorders; Humans; Magnesium; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Nervous System Diseases; Testicular Neoplasms | 1985 |
Enhancement of etoposide-induced cytotoxicity by cyclosporin A.
Topics: Animals; Cells, Cultured; Cisplatin; Cyclosporins; Doxorubicin; Drug Interactions; Etoposide; Humans; Lethal Dose 50; Leukemia L1210; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Mice; Neoplasm Transplantation; Neoplasms, Germ Cell and Embryonal; Radiation, Ionizing | 1986 |
Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
Topics: Aged; Aged, 80 and over; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Uterine Neoplasms | 1987 |